NAME,SEQUENCE,Inhibition Rate (%),Converted Activity,Converted Unit,Sequence_Length,Activity_Score
Cherimolacyclopeptide E,PGLGFY,50.0,0.0170,μM,6,7.7696
MIP(R9A),PRFWEYWLALME,50.0,0.0200,μM,12,7.699
Cherimolacyclopeptide F,PGMGIYLPM,50.0,0.0600,μM,9,7.2218
Phakellistatin 8,IFVLPPYIPP,50.0,0.1000,μM,10,7.0
P. sajor-caju Rnase,DNGEAGRAAR,50.0,0.1000,μM,10,7.0
Cycloviolacin O2,GIPCGESCVWIPCISSAIGCSCKSKVCYRN,50.0,0.1000,μM,30,7.0
Pexiganan MSI-78,GIGKFLKKAKKFGKAFVKILKK,75.0,0.2000,μM,22,6.9657
MIP,PRFWEYWLRLME,50.0,0.1200,μM,12,6.9208
"L10, 11-DPS3",ALWKDILKNLLKAALNEINQIVQ,50.0,0.1200,μM,23,6.9208
Protegrin 1,RGGRLCYCRRRFCVCVGR,61.0,0.2300,μM,18,6.8145
"Cliotides T4, CT4",GIPCGESCVFIPCITAAIGCSCKSKVCYRN,50.0,0.2100,μM,30,6.6778
Phakellistatin 6,PFPWLPI,50.0,0.2100,μM,7,6.6778
DC3,GTSCGETCVLLPCLSSVLGCTCQNKRCYKD,50.0,0.2100,μM,30,6.6778
Citropin 1.1,GLFDVIKKVASVIGGL,60.0,0.3100,μM,16,6.6736
(HHPHG)4,HHPHGHHPHGHHPHGHHPHG,50.0,0.2450,μM,20,6.6108
B7,GISCAETCVLLPCLSSVIGCTCQNKRCYKN,50.0,0.3300,μM,30,6.4815
MIP(M11A),PRFWEYWLRLAE,50.0,0.4000,μM,12,6.3979
Cycloviolacin O3,GIPCGESCVWIPCLTSAIGCSCKSKVCYRN,50.0,0.4200,μM,30,6.3768
Phakellistatin 19,IPWFPLTP,50.0,0.4400,μM,8,6.3565
Melittin,GIGAVLKVLTTGLPALISWIKRKRQQ,102.9,1.0000,μM,26,6.2981
Cycloviolacin-O19,GTLPCGESCVWIPCISSVVGCSCKSKVCYKD,50.0,0.5200,μM,31,6.284
Hyen D,GFPCGESCVYIPCFTAAIGCSCKSKVCYKN,50.0,0.5200,μM,30,6.284
MIP(F3A),PRAWEYWLRLME,50.0,0.5700,μM,12,6.2441
KLW,KWKKLLKKLLKLLKKLLK,50.0,0.6000,μM,18,6.2218
"Cliotides T1, CT1",GIPCGESCVFIPCITGAIGCSCKSKVCYRN,50.0,0.6000,μM,30,6.2218
BLP-7,GIGGALLSAGKSALKGLAKGLAEHFAN,50.0,0.6100,μM,27,6.2147
VGB,CIKPHQGQHICNDE,50.0,0.6100,μM,14,6.2147
Dermaseptin-PH,ALWKEVLKNAGKAALNEINNLVQ,50.0,0.6900,μM,23,6.1612
"Cliotides T10, CT10",GVPCAESCVWIPCTVTALLGCSCKDKVCYLN,50.0,0.7000,μM,31,6.1549
Ltc-2a [G11L],GLFGKLIKKFLRKAISYAVKKARGKH,50.0,0.7000,μM,26,6.1549
"Cliotides T7, CT7",GIPCGESCVFIPCTVTALLGCSCKDKVCYKN,50.0,0.7300,μM,31,6.1367
Psyle E,GVIPCGESCVFIPCISSVLGCSCKNKVCYRD,50.0,0.7600,μM,31,6.1192
Bombinin-BO1,GIGSAILSAGKSIIKGLAKGLA,50.0,0.7600,μM,22,6.1192
Bombinin-BO1,GIGSAILSAGKSIIKGLAKGLAEHF,50.0,0.7600,μM,25,6.1192
"Cliotides T12, CT12",GIPCGESCVYIPCTVTALLGCSCKDKVCYKN,50.0,0.7800,μM,31,6.1079
TsAP-S2,FLGMIPKLIKKLIKAFK,50.0,0.8300,μM,17,6.0809
Chrysophsin-1,FFGWLIKGAIHAGKAIHGLIHRRRH,87.0,~1.7300,μM,25,6.0524
[D9K]Hymenochirin-1Pa,LKLSPKTKKTLKKVLKGAIKGAIAIASMA,50.0,0.9000,μM,29,6.0458
vibi G,GTFPCGESCVFIPCLTSAIGCSCKSKVCYKN,50.0,0.9600,μM,31,6.0177
Phakellistatin 5,AIPFNAM,50.0,~0.9700,μM,7,6.0132
"H-14, Hymenochirin-1B [P5K, E6K, D9K]",IKLSKKTKKNLKKVLKGAIKGAIAVAKMV,50.0,0.9800,μM,29,6.0088
AP,ACDCRGDCFCGGGGIVRRADRAAVP,50.0,0.9900,μM,25,6.0044
Bombinin H-BO,IIGPVLGLIGKALGGLL,50.0,0.9900,μM,17,6.0044
P7,PLLQATLGGGS,50.0,1.0000,μM,11,6.0
[G18K]cTI,KWCFRVCYRGICYRRCRK,50.0,1.0000,μM,18,6.0
Citropin 5,GLFDVIKAVASVIGGL,50.0,1.0000,μM,16,6.0
Citropin 3,GLFAVIKKVASVIGGL,50.0,1.0000,μM,16,6.0
[L5W]cGm,GCRRWCYKQRCVTYCRGR,50.0,1.0000,μM,18,6.0
Chassatide C8,AIPCGESCVWIPCISTVIGCSCSNKVCYR,50.0,1.0000,μM,29,6.0
Citropin 19,GLFAVIKKVAKVIKKL,50.0,1.0000,μM,16,6.0
"Hymenochirin-1B [E6K,D9K]",IKLSPKTKKNLKKVLKGAIKGAIAVAKMV,50.0,1.0000,μM,29,6.0
Ctn[1-14],KRFKKFFKKVKKSV,50.0,1.0000,μM,14,6.0
Puma-BH3,EQWAREIGAQLRRMADDLNA,50.0,1.0060,μM,20,5.9974
Viphi F,GSIPCGESCVFIPCISAIIGCSCSSKVCYKN,50.0,1.0300,μM,31,5.9872
Viphi G,GSIPCGESCVFIPCISAIIGCSCSNKVCYKN,50.0,1.0300,μM,31,5.9872
B5,GAVPCGESCVYLPCLTTVVGCSCQNSVCYHN,50.0,1.0300,μM,31,5.9872
From_Paper_8,FHPSLWVLIPQYIQLIRKILKSG,50.0,1.0900,μM,23,5.9626
"Hymenochirin-1B [P5K,E6K]",IKLSKKTKDNLKKVLKGAIKGAIAVAKMV,50.0,1.1000,μM,29,5.9586
Hymenochirin-1B [D9K],IKLSPETKKNLKKVLKGAIKGAIAVAKMV,50.0,1.1000,μM,29,5.9586
B1-Leu,VKRFKKFFRKLKKLV,50.0,1.1000,μM,15,5.9586
B9,GNPCGESCVYLPCITTVVGCSCQNSVCYHN,50.0,1.1400,μM,30,5.9431
MIP(L10A),PRFWEYWLRAME,50.0,1.1400,μM,12,5.9431
Hyen M,SIPCAESCVWIPCTVTALLGCSCSDKVCYN,50.0,1.1600,μM,30,5.9355
"Hymenochirin-1B [P5K,D9K]",IKLSKETKKNLKKVLKGAIKGAIAVAKMV,50.0,1.1700,μM,29,5.9318
Hymenochirin-1B [E6K],IKLSPKTKDNLKKVLKGAIKGAIAVAKMV,50.0,1.2000,μM,29,5.9208
Chassatide C7,IPCGESCVWIPCITAIAGCSCKNKVCYT,50.0,1.2000,μM,28,5.9208
Chassatide C11,IPCGESCVWIPCISGMFGCSCKDKVCYS,50.0,1.2000,μM,28,5.9208
[R17S]cTI,KWCFRVCYRGICYRRCSG,50.0,1.2000,μM,18,5.9208
Hymenochirin-1Pa,LKLSPKTKDTLKKVLKGAIKGAIAIASMA,50.0,1.2000,μM,29,5.9208
[I11F-G18K]cTI,KWCFRVCYRGFCYRRCRK,50.0,1.3000,μM,18,5.8861
"[G1K,L5Y,K8R]cGm",KCRRYCYRQRCVTYCRGR,50.0,1.3000,μM,18,5.8861
Camel,KWKLFKKIGAVLKVL,50.0,1.3000,μM,15,5.8861
P4,KWKLFKKIGIGKFLHLAKKF,50.0,1.3000,μM,20,5.8861
B1-Phe,VKRFKKFFRKLKKFV,50.0,1.3000,μM,15,5.8861
Cyclotide mela-2,GKPTCGETCFKGKCYTPGCTCSYPLCKKD,50.0,1.3000,μM,29,5.8861
cTI,KWCFRVCYRGICYRRCRG,50.0,1.3000,μM,18,5.8861
Viba 15,GLPVCGETCVGGTCNTPGCACSWPVCTRN,50.0,1.3200,μM,29,5.8794
Viba 17,GLPVCGETCVGGTCNTPGCGCSWPVCTRN,50.0,1.3200,μM,29,5.8794
"Varv A, Kalata B1 [T20S]",GLPVCGETCVGGTCNTPGCSCSWPVCTRN,50.0,1.3400,μM,29,5.8729
Hymenochirin-1B [P5K],IKLSKETKDNLKKVLKGAIKGAIAVAKMV,50.0,1.4000,μM,29,5.8539
CPe-III(CPe-III-S),RQSHFANAQP,50.0,1.5000,μM,10,5.8239
TsAP-S1,FLSLIPKLVKKIIKAFK,50.0,1.5000,μM,17,5.8239
TI,KWCFRVCYRGICYRRCR,50.0,1.5000,μM,17,5.8239
Hyen L,GIPCAESCVYIPCTVTALLGCSCSDKVCYN,50.0,1.5400,μM,30,5.8125
Dermaseptin-PP,ALWKDMLKGIGKLAGKAALGAVKTLV,50.0,1.5500,μM,26,5.8097
vitri A,GIPCGESCVWIPCITSAIGCSCKSKVCYRN,50.0,1.5500,μM,30,5.8097
(HHPHG)3,HHPHGHHPHGHHPHG,50.0,1.5600,μM,15,5.8069
Cyclotide mela-6,GLPTCGETCFKGKCYTPGCSCSYPICKKD,50.0,1.5800,μM,29,5.8013
Cyclotide mela-7,GLPTCGETCFKGKCYTPGCSCSYPICKKN,50.0,1.5800,μM,29,5.8013
DI,LTFEHYWAQLTS,50.0,1.6000,μM,12,5.7959
vibi H,GLLPCAESCVYIPCLTTVIGCSCKSKVCYKN,50.0,1.6000,μM,31,5.7959
vitri F,GTLPCGESCVWIPCISSVVGCACKSKVCYKD,50.0,1.6600,μM,31,5.7799
Kassinatuerin-3,FIQHLIPLIPHAIQGIKDIF,50.0,1.6700,μM,20,5.7773
P6,KWKLFKKIGIGKFKLAKKF,50.0,1.7000,μM,19,5.7696
"[G1K,K8R]cGm",KCRRLCYRQRCVTYCRGR,50.0,1.7000,μM,18,5.7696
[R14S]cTI,KWCFRVCYRGICYSRCRG,50.0,1.7000,μM,18,5.7696
Peptide P,KWKSFLKTFKSLKKTVLHTLLKAISS,50.0,1.7100,μM,26,5.767
"Palustrin-2ISb (1-29), GL-29",GLWNSIKIAGKKLFVNVLDKIRCKVAGGC,50.0,1.7400,μM,29,5.7595
Mram 8,GIPCGESCVFIPCLTSAIGCSCKSKVCYRN,50.0,1.7500,μM,30,5.757
Viphi A,GSIPCGESCVFIPCISSVIGCACKSKVCYKN,50.0,1.7500,μM,31,5.757
P8,KWKKFLKIGIGKFLHLAKKF,50.0,1.8000,μM,20,5.7447
Phylloseptin-Pba,FFSMIPKIAGGIASLVKNL,50.0,1.8000,μM,19,5.7447
HPRP-A1-TAT,FKKLKKLFSKLWNWKRKKRRQRRR,50.0,1.8000,μM,24,5.7447
Phylloseptin-PBa,FFSMIPKIAGGIASLVKNLG,50.0,1.8000,μM,20,5.7447
B6,GAVPCGETCVYLPCITAAIGCSCQNKVCYRD,50.0,1.8500,μM,31,5.7328
GGN6 (gaegurin 6),FLPLLAGLAANFLPTIICKISYKC,50.0,1.8700,μM,24,5.7282
B8,GIPCGESCAFLPCLTSLLGCTCQNKVCYRD,50.0,1.8800,μM,30,5.7258
Piscidin 3 Cu2+,FIHHIFRGIVHAGRSIGRFLTG,50.0,1.9700,μM,22,5.7055
FLAK01 AM,FALAAKALKKLAKKLKKLAKKAL,50.0,2.0000,μM,23,5.699
[W2S]cTI,KSCFRVCYRGICYRRCRG,50.0,2.0000,μM,18,5.699
"Cliotides T3, CT3",GLPTCGETCTLGTCYVPDCSCSWPICMKN,50.0,2.0000,μM,29,5.699
V681 [V13L],KWKSFLKTFKSALKTVLHTALKAISS,50.0,2.0000,μM,26,5.699
Short α-helical peptides,GIIKKIIKKI,99.0,4.0000,μM,10,5.6957
Short α-helical peptides,GIIKKIIKKIIKKI,95.0,~4.0000,μM,14,5.6942
Cyclotide mela-3,GKPICGETCFKGKCYTPGCTCSYPICKKD,50.0,2.0400,μM,29,5.6904
Cyclotide mela-4,GKPICGETCFKGKCYTPGCTCSYPICKKN,50.0,2.0400,μM,29,5.6904
Cyclotide mela-1,GKYTCGETCFKGKCYTPGCTCSYPICKKD,50.0,2.0900,μM,29,5.6799
Short α-helical peptides,GIIKKIIKKIIKKIIKKI,80.0,~4.0000,μM,18,5.6779
Warnericin RK,MQFITDLIKKAVDFFKGLFGNK,50.0,2.1100,μM,22,5.6757
Piscidin 1 Cu2+,FFHHIFRGIVHVGKTIHRLVTG,50.0,2.1500,μM,22,5.6676
A12L/A20L/A23L,KWKSFLKTFKSLKKTVLHTLLKLISS,50.0,2.2000,μM,26,5.6576
Brevinin-1HY,FALGAVTKVLYKLFCLITRKC,50.0,2.2430,μM,21,5.6492
LL-37 (17-29) [K25L],FKRIVQRILDFLR,50.0,2.2900,μM,13,5.6402
V681 [V13A],KWKSFLKTFKSAAKTVLHTALKAISS,50.0,2.3300,μM,26,5.6326
Phakellistatin 10,IPYVPLTP,50.0,2.3400,μM,8,5.6308
cyclosaplin,RLGDGCTR,50.0,2.3500,μM,8,5.6289
Hecate Ac,FALALKALKKALKKLKKALKKAL,50.0,2.3600,μM,23,5.6271
Chassatide C2,GIPCAESCVWIPCTITALMGCSCKNNVCYNN,50.0,2.4000,μM,31,5.6198
P7,KWKLFAKIGIGKFLHLAKKF,50.0,2.4000,μM,20,5.6198
Phakellistatin 12,PPIFTLPPYI,50.0,2.4200,μM,10,5.6162
DMS-PS1,GLWKSLFKNVGKAAGKAALNAVTDMVNQ,50.0,2.4440,μM,28,5.6119
Tyroserleutide,YSL,51.2,2.6200,μM,3,5.607
RL1,RLLRLLRRLLRLLR,50.0,2.5000,μM,14,5.6021
FR-15,FRRFFKWFRRFFKFF,50.0,2.5000,μM,15,5.6021
[R/K]cTI,KWCFKVCYKGICYKKCKG,50.0,2.5000,μM,18,5.6021
FR4P,FRRPFKWFRRFFKFF,50.0,2.5000,μM,15,5.6021
Hymenochirin-1B,IKLSPETKDNLKKVLKGAIKGAIAVAKMV,50.0,2.5000,μM,29,5.6021
PM III,RRGCFRVCYRGFCFQRCR,50.0,2.5000,μM,18,5.6021
Ps-1Pb,IKIPSFFRNILKKVGKEAVSLIAGALKQS,50.0,2.5000,μM,29,5.6021
Cyclotide cter-E,GIPCAESCVWIPCTVTALLGCSCKDKVCYLD,50.0,2.5000,μM,31,5.6021
IDP-LLCb01,RRRRRRRSKAPKVVILSKALEYLQA,50.0,~2.5000,μM,25,5.6021
Viphi D,GIPCGESCVFIPCISSVIGCSCSSKVCYRN,50.0,2.5100,μM,30,5.6003
Viphi E,GSIPCGESCVFIPCISAVIGCSCSNKVCYKN,50.0,2.5100,μM,31,5.6003
di-PST13-RK-C,KKKFPWWWPFKKKCKKKFPWWWPFKKKC,50.0,2.5900,μM,28,5.5867
Brevinin-1H,FALGAVTKVLPKLFCLITRKC,50.0,2.5990,μM,21,5.5852
Vaby D(4),GLPVCGETCFGGTCNTPGCTCDPWPVCTRN,50.0,2.6000,μM,30,5.585
Not available,KAMKSIAKFIAK,80.0,<5.0000,μM,12,5.581
Varv F,GVPICGETCTLGTCYTAGCSCSWPVCTRN,50.0,2.6300,μM,29,5.58
Hyen E,GVPCGESCVYIPCFTGIINCSCRDKVCYNN,50.0,2.6400,μM,30,5.5784
di-PST13-RK-K,KKKFPWWWPFKKKKKKFPWWWPFKKKK,50.0,2.6500,μM,27,5.5768
DC2,GAVPCGETCVYLPCITPDIGCSCQNKVCYRD,50.0,2.6500,μM,31,5.5768
FLAK 26 AM,FAKKLAKLAKKLAKLAL,50.0,2.6900,μM,17,5.5702
CI-15,CIIKKIIKKIIKKII,50.0,2.7000,μM,15,5.5686
[Y14W]cGm,GCRRLCYKQRCVTWCRGR,50.0,2.7000,μM,18,5.5686
cGm,GCRRLCYKQRCVTYCRGR,50.0,2.7000,μM,18,5.5686
tMP-C,RKKRRQRRRLNLKALLAVAKKIL,50.0,2.7900,μM,23,5.5544
Buforin IIb,RAGLQFPVGRLLRRLLRRLLR,50.0,2.8100,μM,21,5.5513
NRC-14,AGWGSIFKHIFKAGKFIHGAIQAHND,50.0,2.8100,μM,26,5.5513
Cecropin A (2-8) + Melittin (6-9),WKLFKKILKVL,50.0,2.8300,μM,11,5.5482
Phakellistatin 7,PPIFALPPYI,50.0,2.8400,μM,10,5.5467
PSN-PC,FLSLIPKIATGIAALAKHL,50.0,2.8500,μM,19,5.5452
P5,KWKLFKKIGIGAFLHLAKKF,50.0,2.9000,μM,20,5.5376
A20L,KWKSFLKTFKSAKKTVLHTLLKAISS,50.0,2.9000,μM,26,5.5376
IC,IVRRADRAAVPGGGGACDCRGDCFC,60.0,4.3500,μM,25,5.5265
[S9]-P18,KWKLFKKISKFLHLAKKF,50.0,3.0000,μM,18,5.5229
L5,PAWRKAFRWAWRMLKKAA,50.0,3.0000,μM,18,5.5229
LL-III/18,KNWKKILKKIIKVVK,50.0,3.0000,μM,15,5.5229
LL-III/1,VNWKKILAKIIKVVK,50.0,3.0000,μM,15,5.5229
Cyclotide cter-G,GLPCGESCVFIPCITTVVGCSCKNKVCYNN,50.0,3.0000,μM,30,5.5229
N-4L,WFKKIPKFLHLLKKF,50.0,3.0000,μM,15,5.5229
[L9]-P18,KWKLFKKILKFLHLAKKF,50.0,3.0000,μM,18,5.5229
Temporin-PE - Tat (48–57),FLPIVAKLLSGLLGRKKRRQRRR,50.0,3.0510,μM,23,5.5156
[K8R]cGm,GCRRLCYRQRCVTYCRGR,50.0,3.1000,μM,18,5.5086
vibi E,GIPCAESCVWIPCTVTALIGCGCSNKVCYN,50.0,3.2000,μM,30,5.4949
RFR-ChBac3.4-1-NH2,RFRRFRLPFRRIHPPPFVRIHPPPFYRRFL,50.0,3.2000,μM,30,5.4949
LXP-7,RAGLQFPVGKLLKKLLKKLLK,50.0,3.2000,μM,21,5.4949
Kalata B1 [N15Y],GLPVCGETCVGGTCYTPGCTCSWPVCTRN,50.0,3.2000,μM,29,5.4949
Dermaseptin DRS-DU-1,ALWKSLLKNVGKAAGKAALNAVTDMVNQ,50.0,3.2100,μM,28,5.4935
From_Paper_1,GFLSILKKVLPKVMAHMK,50.0,3.2600,μM,18,5.4868
Latarcin 2a,GLFGKLIKKFGRKAISYAVKKARGKH,50.0,3.3000,μM,26,5.4815
I-5,VRRFRRFFRRLRRSVL,50.0,3.3000,μM,16,5.4815
KL1,KLLKLLKKLLKLLK,50.0,3.3000,μM,14,5.4815
ChMAP-28,GRFKRFRKKLKRLWHKVGPFVGPILHY,50.0,3.3900,μM,27,5.4698
Temporin-PE [P3Y],FLYIVAKLLSGLL,50.0,3.3980,μM,13,5.4688
P1,KWKLFKKIGIGAVLKVLKKG,50.0,3.4000,μM,20,5.4685
Psyle C,KLCGETCFKFKCYTPGCSCSYPFCK,50.0,3.5000,μM,25,5.4559
P18,KWKFKKIPKFLHLAKKF,50.0,3.5000,μM,17,5.4559
HPRP-A1,FKKLKKLFSKLWNWK,50.0,3.5000,μM,15,5.4559
PTP7,FLGALFKALSKLL,50.0,3.5300,μM,13,5.4522
PTP5,FLKLLKKLAAKLF,50.0,3.5400,μM,13,5.451
FLAK05 AM,FALAKLAKKAKAKLKKALKAL,50.0,3.5500,μM,21,5.4498
Antifungal lectin PVAP,SNDIYFNFQR,50.0,3.6000,μM,10,5.4437
Bombinin H-BO1,IIGPVLGLVGKALGGLL,50.0,3.6100,μM,17,5.4425
C7A,KILRGVAKKILRTFLRRISKDILTGKK,50.0,3.7000,μM,27,5.4318
A12L,KWKSFLKTFKSLKKTVLHTALKAISS,50.0,3.8000,μM,26,5.4202
I-6,VRRFRRFFRRLRRSVLL,50.0,3.8000,μM,17,5.4202
Kalata-B13,GLPVCGETCFGGTCNTPGCACDPWPVCTRD,50.0,3.8000,μM,30,5.4202
B18L,GLGKALAKALACLAKALA,50.0,3.8000,μM,18,5.4202
FLAK06 AM,FALALKALKKLKKALKKAL,50.0,3.8200,μM,19,5.4179
B1AW-K,FLPLLAGLAANFLPKIICKIARKC,50.0,3.8600,μM,24,5.4134
FLAK26V AM,VAKKLAKLAKKLAKLAL,50.0,3.8700,μM,17,5.4123
[Y7W]cGm,GCRRLCWKQRCVTYCRGR,50.0,3.9000,μM,18,5.4089
Phakellistatin 18,PYPIFPI,50.0,3.9000,μM,7,5.4089
"[Y7W,K8R,Y14W]cGm",GCRRLCWRQRCVTWCRGR,50.0,3.9000,μM,18,5.4089
From_Paper_4,INWLKLGKKILGAI,50.0,3.9100,μM,14,5.4078
FLAK04 AM,FALALKALKKLAKKLKKLAKKAL,50.0,3.9400,μM,23,5.4045
LL-III/23,VNWKKLLGKLLKVVK,50.0,4.0000,μM,15,5.3979
LL-III/37,VNWKKVLAKIIKVVK,50.0,4.0000,μM,15,5.3979
Brevinin-1VLa,FLGAIAGVAAKFLPKVFCFITKKC,50.0,4.0000,μM,24,5.3979
Brevinin-1VLd,FLPLIAGVAANFLPKIFCLISKKC,50.0,4.0000,μM,24,5.3979
Cationic Amphiphilic,GIIKKIIIKKIIIKKIIIKKI,50.0,4.0000,μM,21,5.3979
HAL-1/18,GMWSKILKHLIR,50.0,4.0000,μM,12,5.3979
LL-III/11,VNWKKIILGKIIKVVK,50.0,4.0000,μM,16,5.3979
Arenicin-1,RWCVYAYVRVRGVLVRYRRCW,50.0,4.0000,μM,21,5.3979
LL-III,VNWKKILGKIIKVVK,50.0,4.0000,μM,15,5.3979
N-3L,KWFKKIPKFLHLLKKF,50.0,4.0000,μM,16,5.3979
"Phylloseptin-PHa [A7K, A8I, V12I, A16I, N17K]",FLSLIPKIISAISALIKHF,50.0,4.0590,μM,19,5.3916
Brevinin-1DYa,FLSLALAALPKFLCLVFKKC,50.0,4.1000,μM,20,5.3872
ChBac3.4-2-COOH,RFRLPFRRPWPIRIHPPPFYPWPFRRFL,50.0,4.1000,μM,28,5.3872
TsAP-2 (T. serrulatus antimicrobial peptide 2),FLGMIPGLIGGLISAFK,50.0,4.1000,μM,17,5.3872
FLAK50,FAKLLAKLAKKLL,50.0,4.1200,μM,13,5.3851
CA (1-7) Shiva10 (1-16),KWKLFKKKTKLFKKFAKKLAKKL,50.0,4.1700,μM,23,5.3799
FR8P,FRRFFKWPRRFFKFF,50.0,4.2000,μM,15,5.3768
I-7,LVRRFRRFFRRLRRSVLL,50.0,4.2000,μM,18,5.3768
SHIVA DERIV P69 + KWKL,FAKKLAKKLKKLAKKLAKKWKL,50.0,4.2100,μM,22,5.3757
maximin 3,GIGGKILSGLKTALKGAAKELASTYLH,50.0,4.2300,μM,27,5.3737
RL2,RLLRLLRLRRLLRL,50.0,4.3000,μM,14,5.3665
Helical1,FLWIKLGKLAGAVLKLILGLKKVV,50.0,4.4000,μM,24,5.3565
HS7,GAISAPKLQIND,50.0,4.4000,μM,12,5.3565
FLAK 25 AM,FAKKLAKLAKKLAKLALAL,50.0,4.4100,μM,19,5.3556
SSTP1,FLPLLISALTSLFPKLGK,50.0,4.5000,μM,18,5.3468
Brevinin-1DYb,FLSLALAALPKLFCLIFKKC,50.0,4.5000,μM,20,5.3468
ChBac3.4-1-NH2,RFRLPFRRIHPPPFVRIHPPPFYRRFL,50.0,4.5000,μM,27,5.3468
CA(1-& HECATE(11/23),KWKLFKKALKKLKKALKKAL,50.0,4.5600,μM,20,5.341
FLAK50 Q1,FAKFLAKFLKKAL,50.0,4.5900,μM,13,5.3382
RW-AH,WWRRWWRRWRRWWRRWWR,50.0,4.6000,μM,18,5.3372
11,GLFAILKKLVNLVG,50.0,4.6000,μM,14,5.3372
Pardaxin-6,GFFALIPKIISSPLFKTLLSAVGSALS,84.0,~8.9980,μM,27,5.3326
Bacteriocin TP,ASVVNKLTGGVAGLLK,50.0,4.6860,μM,16,5.3292
P,KWKSFLKTFKSAKKTVLHTALKAISS,50.0,4.7000,μM,26,5.3279
HYL-9,GIMSSLMKALAAHIAK,50.0,4.7500,μM,16,5.3233
[R9S-R14S-R17S]cTI,KWCFRVCYSGICYSRCSG,50.0,4.8000,μM,18,5.3188
FR11P,FRRFFKWFRRPFKFF,50.0,4.8000,μM,15,5.3188
FLAK50D,FAKLLAKALKKLL,50.0,4.8000,μM,13,5.3188
Magainin B,GIGKFLHAAKKFAKAFVAEIMNS,50.0,4.8400,μM,23,5.3152
B1-Val,VKRFKKFFRKLKKVV,50.0,4.9000,μM,15,5.3098
PTP4,FLKLLKKLAAKFLPTIICKISYKC,50.0,4.9300,μM,24,5.3072
INKKI peptide,INKKI,50.0,4.9900,μM,5,5.3019
IDP-NS02,RQRRNKLRSKFLTLRDH,50.0,5.0000,μM,17,5.301
"[Lys5, Lys15, Lys16] XT-7",GLLGKLLKIAAKVGKKLL,50.0,5.0000,μM,18,5.301
Mastoparan,INLKALAALAKKIL,50.0,5.0000,μM,14,5.301
LL-III/34,NKWKKILGKIIKVVK,50.0,5.0000,μM,15,5.301
"FR4, 8P",FRRPFKWPRRFFKFF,50.0,5.0000,μM,15,5.301
R-DIM-LF11-337,PFWRRRIRIRRRRIRIRRRWFP,50.0,5.0000,μM,22,5.301
NLCa02,RRRRRRRRQRRNDLRSSFLTLRDHVP,50.0,~5.0000,μM,26,5.301
Chassatide C10,GEYCGESCYLIPCFTPGCYCVSRQCVNKN,50.0,5.0000,μM,29,5.301
B1-His,VKRFKKFFRKLKKHV,50.0,5.0000,μM,15,5.301
N-4L,WKKIPKFLHLLKKF,50.0,5.0000,μM,14,5.301
PenShufArgLeu,RWFRIQLQIRRWRNRR,50.0,5.0000,μM,16,5.301
LL-III/26,VYWKKILGKIIKVVK,50.0,5.0000,μM,15,5.301
TP III,KWCFRVCYRGICYRKCR,50.0,5.0000,μM,17,5.301
vCPP 2319,WRRRYRRWRRRRRWRRRPRR,50.0,5.0200,μM,20,5.2993
Temporin-1Tl,FVQWFSKFLGRIL,100.0,10.0000,μM,13,5.2981
MPI,IDWKKLLDAAKQIL,50.0,5.0600,μM,14,5.2958
EGFR-related peptide,ERRP,70.0,8.9800,μM,4,5.2926
HYL-11,GIMSSLMKKLAAAIAK,50.0,5.1800,μM,16,5.2857
"Pro-apoptotic peptide, PAP",KLAKLAKKLAKLAK,82.0,10.0000,μM,14,5.2837
FLAK 17 AM,FALALKKALKALKKAL,50.0,5.2100,μM,16,5.2832
Synthetic peptide,KWKKLLKKPPPLLKKLLKKL,80.0,~10.0000,μM,20,5.2799
[R9S]cTI,KWCFRVCYSGICYRRCRG,50.0,5.3000,μM,18,5.2757
"LTV-PAP, LTV-KLA",LTVSPWYGCGKLAKLAKKLAKLAK,78.0,10.0000,μM,24,5.2754
"LTV-HEXIM1 (147-164)[K4,5,6,13,14,15R], LTV-BR (RRR12)",LTVSPWYGCGQLGRRRHRRRPSRRRRHW,78.0,10.0000,μM,28,5.2754
HYL-5,GIMSALMKKLAAHIAK,50.0,5.3200,μM,16,5.2741
From_Paper_3,FIGGIISLIKKLF,50.0,5.3400,μM,13,5.2725
Warnericin RK [G20D],MQFITDLIKKAVDFFKGLFDNK,50.0,5.3900,μM,22,5.2684
Phakellistatin 16,PFDSRAVTY,50.0,5.4000,μM,9,5.2676
GK-3,RWRLFKRIGIGRLLKRGLR,50.0,5.4281,μM,19,5.2654
Brevinin-1RL1,FFPLIAGLAARFLPKIFCSITKRC,50.0,5.4400,μM,24,5.2644
Epinecidin-1,GFIFHIIKGLFHAGKMIHGLV,90.0,~10.7020,μM,21,5.2637
From_Paper_2,FIGAALGALTAIPSIIKLFK,50.0,5.4600,μM,20,5.2628
B1-Lys,VKRFKKFFRKLKKKV,50.0,5.5000,μM,15,5.2596
B1-Arg,VKRFKKFFRKLKKRV,50.0,5.5000,μM,15,5.2596
NRC-123,GWKDWFRKAKKVGKTVGGLALNHYL,50.0,5.5700,μM,25,5.2541
ES-2,IVRRADRAAVP,60.0,8.1737,μM,11,5.2526
TP II,RWCFRVCYRGICYRKCR,50.0,5.6000,μM,17,5.2518
HS4,GAISLAPKLQINE,50.0,5.6000,μM,13,5.2518
Ranatuerin-2SSa,GLISTIWNTASNVAGTLTDSVKCKFKKC,80.3,10.7200,μM,28,5.2503
AmphiArc2,KIFKKFKTIIKKVWRIFGRF,50.0,5.7000,μM,20,5.2441
lunatusin,KTCENLADTFRGPCFATSNC,50.0,5.7100,μM,20,5.2434
maximin 1,GIGTKILGGVKTALKGALKELASTYAN,50.0,5.7200,μM,27,5.2426
NRC-125,GLKKWFKKAVHVGKKVGKVALNAYL,50.0,5.7500,μM,25,5.2403
R2PLx,GIMDTVKNAAKNLAGQLLDKLKCKITAC,50.0,5.7900,μM,28,5.2373
NRC-11,GWKSVFRKAKKVGKTVGGLALDHYL,50.0,5.8000,μM,25,5.2366
B4,LKKLFKKILKYL,50.0,5.9000,μM,12,5.2291
Hymenochirin-4B,IKIPAFVKDTLKKVAKGVISAVAGALTQ,50.0,5.9000,μM,28,5.2291
"Pleurocidin, NRC-04",GWGSFFKKAAHVGKHVGKAALTHYL,50.0,5.9000,μM,25,5.2291
"LL-37 (17-29) [R23L,I24L,D26K,F27L]-Ac",FKRIVQLLKKLLR,50.0,5.9200,μM,13,5.2277
HAL-2/2,GKWMKLLKHILK,50.0,6.0000,μM,12,5.2218
"[Lys4, Lys5, Lys15, Lys16] XT-7",GLLKKLLKIAAKVGKKLL,50.0,6.0000,μM,18,5.2218
"Alyteserin-2a [A10W, N15K]",ILGKLLSTAWGLLSKL,50.0,6.0000,μM,16,5.2218
LL-III/6,VNWKKILPKIIKVVK,50.0,6.0000,μM,15,5.2218
Brevinin-1BYa,FLPILASLAAKFGPKLFCLVTKKC,50.0,6.0000,μM,24,5.2218
N-1,WKLFKKIPKFLHLAKKF,50.0,6.0000,μM,17,5.2218
Brevinin-1BLc,FLPIIAGIAAKFLPKIFCTISKKC,50.0,6.0000,μM,24,5.2218
Ps-2Pa,GIFPIFAKLLGKVIKVASSLISKGRTE,50.0,6.0000,μM,27,5.2218
"Alyteserin-2a [G11K, N15K]",ILGKLLSTAAKLLSKL,50.0,6.0000,μM,16,5.2218
Brevinin-1VLc,FLPVIASVAAKVLPKVFCFITKKC,50.0,6.0000,μM,24,5.2218
HYL-4,GIMASLMKKLAAHIAK,50.0,6.0100,μM,16,5.2211
FLAK43 AM,FAKKLAKLAKKLLAL,50.0,6.0400,μM,15,5.219
FLAK50 T2,FAKLLAKLAKKVL,50.0,6.2400,μM,13,5.2048
MP-C,LNLKALLAVAKKIL,50.0,6.2900,μM,14,5.2013
Indolocidin-ac,ILPWKWPWWPWRR,50.0,6.2900,μM,13,5.2013
YALPAH,YALPAH,50.0,6.3200,μM,6,5.1993
Ranalexin,FLGGLIKIVPAMICAVTKKC,50.0,6.3600,μM,20,5.1965
From_Paper_7,LKLLGIVKKVLGAI,50.0,6.3800,μM,14,5.1952
Cyclopeptide GG-8-6,VLPILLLVL,50.0,6.3800,μM,9,5.1952
NRC-17,GWKKWLRKGAKHLGQAAIKGLAS,50.0,6.3900,μM,23,5.1945
I-3,LVKRFKKFFRKLKKSVLL,50.0,6.5000,μM,18,5.1871
AmphiArc2 Off2.2.6,QLIKKLRTWYRKAWHVLGKL,50.0,6.5000,μM,20,5.1871
lytic(L),KLLLKLLKKLLKLLKKK,50.0,6.5000,μM,17,5.1871
TG20,NHFTLKCPKTALTEPPTLAY,45.0,~1.0000,μM,20,5.8780
BP100 [Y10L],KKLFKKILKLL,50.0,6.6000,μM,11,5.1805
Phylloseptin-PT,FLSLIPKIAGGIAALAKHL,50.0,6.7300,μM,19,5.172
"TAT(48-57)-G-Dermaseptin DRS-DU-1 (1-13), DP-2",GRKKRRQRRRGALWKSLLKNVGKA,50.0,6.7500,μM,24,5.1707
Tritrp-P9A,VRRFPWWWAFLRR,50.0,6.8000,μM,13,5.1675
Epinecidin-8,FIFHIIKGLFHAGKMI,85.0,~13.3520,μM,16,5.1626
Hymenochirin-2B,LKIPGFVKDTLKKVAKGIFSAVAGAMTPS,50.0,6.9000,μM,29,5.1612
N-2,FKLFKKIPKFLHLAKKF,50.0,7.0000,μM,17,5.1549
Brevinin-1VLe,FLPLIAGVAASILPKIFCFITKKC,50.0,7.0000,μM,24,5.1549
LL-III/4,VNWKKILGKIKKVVK,50.0,7.0000,μM,15,5.1549
AmphiArc1,KWVKKVHNWLRRWIKVFEALFG,50.0,7.0000,μM,22,5.1549
LL-III/15,VNFKKLLGKLLKVVK,50.0,7.0000,μM,15,5.1549
LH02,RRRRRRRRVKLVNLGFATLREHVP,50.0,~7.0000,μM,24,5.1549
AmphiArc2 Off2.2.3,HLLKKWRTWLRKAWHIVGKV,50.0,7.0000,μM,20,5.1549
Alyteserin-2a [A10W],ILGKLLSTAWGLLSNL,50.0,7.0000,μM,16,5.1549
Decoralin [AC2],RLLRLIRKLIL,50.0,7.0000,μM,11,5.1549
LL-III/2,NVWKKILGKIIKVVK,50.0,7.0000,μM,15,5.1549
cMP-C,CLNLKALLAVAKKILC,50.0,7.0200,μM,16,5.1537
LL-37 (17-29) [K25R]-Ac,FKRIVQRIRDFLR,50.0,7.1500,μM,13,5.1457
PM II,RRWCFRVCYKGFCYRKCR,50.0,7.2000,μM,18,5.1427
PM I,RRWCFRVCYRGFCYRKCR,50.0,7.2000,μM,18,5.1427
"Ixosin [E8K,E13L,S16V], Ixosin-pch",GLHKVMRKVLGYLRNVYK,24.0,1.0000,μM,18,5.1407
From_Paper_6,FLSAITSILGKLF,50.0,7.3100,μM,13,5.1361
ZXR-2,FKIGGFIKKLWRSLLA,50.0,7.5000,μM,16,5.1249
"Cliotides T2, CT2",GEFLKCGESCVQGECYTPGCSCDWPICKKN,50.0,7.5900,μM,30,5.1198
Vaby A(1),GLPVCGETCAGGTCNTPGCSCSWPICTRN,50.0,7.6000,μM,29,5.1192
BP100 [Y10H],KKLFKKILKHL,50.0,7.6000,μM,11,5.1192
B8,LKKLFKKILKY,50.0,7.6000,μM,11,5.1192
FLAK50I,FAKLLALALKLKL,50.0,7.6300,μM,13,5.1175
From_Paper_5,IIGHLIKTALGFLGL,50.0,7.6400,μM,15,5.1169
"LL-37 (17-29) [R23I,D26K]-Ac",FKRIVQIIKKFLR,50.0,7.6400,μM,13,5.1169
TAT-WLP,FSLNWRPPCLFYGRKKRRQRRR,50.0,7.6900,μM,22,5.1141
"Arenicin-1 [R1,9,11,16,18,19K]",KWCVYAYVKVKGVLVKYKKCW,50.0,7.7000,μM,21,5.1135
L12,PAWRKAFRWAKRMLKKAA,50.0,7.9000,μM,18,5.1024
Brevinin-1ITa,IVPFLLGMVPKLVCLITKKC,50.0,8.0000,μM,20,5.0969
mPep1,RKAFRWAWRMLKKAAPSITCVR,50.0,8.0000,μM,22,5.0969
AmphiArc2 Off2.2.7,QIIKKVRTWIKKAWHLIGKI,50.0,8.0000,μM,20,5.0969
MAC1/9,GFKMALKLLKKVL,50.0,8.0000,μM,13,5.0969
EH-APP(1-22)-Melittin (21-26),GEILCNLCTGLINTLENLLTTKRKRQQ,50.0,8.0000,μM,27,5.0969
9S1R,RRRRRWCMNW,50.0,8.0000,μM,10,5.0969
PGYa,GLLRRLRDFLKKIGEKFKKIGY,50.0,≤8.0000,μM,22,5.0969
[Lys8] Ascaphin-8,GFKDLLKKAAKALVKTVLF,50.0,8.0000,μM,19,5.0969
ChBac3.4-NH2,RFRLPFRRPPIRIHPPPFYPPFRRFL,50.0,8.1000,μM,26,5.0915
Diketopiperazine (YC),YC,54.61,10.0000,μM,2,5.0887
LL-37 (17-29) [R23L]-Ac,FKRIVQLIKDFLR,50.0,8.2900,μM,13,5.0814
Alliumin,DDFLCAGGCL,50.0,8.3300,μM,10,5.0794
Di-PuroA,FPVTWRWWKWWKGKFPVTWRWWKWWKG,50.0,8.3400,μM,27,5.0788
SEQ ID NO.01 of Patent CN 113234128A,LLRHVVKILKYLHGVSGHGQHGVHG,50.0,8.3450,μM,25,5.0786
PEP01,ELQSTGRKVA,52.0,9.1900,μM,10,5.0779
HPRP-A1-RGD,FKKLKKLFSKLWNWKRGD,50.0,8.4000,μM,18,5.0757
Phakellistatin 15,PWIPLTPL,50.0,8.5000,μM,8,5.0706
Dermaseptin S4 [M4D][N20D],ALWDTLLKKVLKAAAKAALDAVLVGANA,50.0,8.5100,μM,28,5.0701
Hepcidin TH1-5,GIKCRFCCGCCTPGICGVCCRF,50.0,8.5840,μM,22,5.0663
DAP1,LWKRWVGVWRKWL,50.0,8.6000,μM,13,5.0655
1,ALFGILKKAFGKILTIFAGLPGVV,50.0,8.6000,μM,24,5.0655
B1-Ala,VKRFKKFFRKLKKAV,50.0,8.6000,μM,15,5.0655
PTP6,FLKLLKKLAAKFL,50.0,8.6600,μM,13,5.0625
mt_S20A/L22 W/P27A,ETFADWWKLLAE,50.0,8.7000,μM,12,5.0605
Apo E,LRVRLASHLRKLRKRLLRDADDLQKRLAVY,55.0,10.8900,μM,30,5.0581
Warnericin RK [F14V],MQFITDLIKKAVDVFKGLFGNK,50.0,8.7900,μM,22,5.056
Hymenochirin-3B,IKIPAVVKDTLKKVAKGVLSAVAGALTQ,50.0,8.8000,μM,28,5.0555
Phakellistatin 1,PIPIFPY,50.0,8.8700,μM,7,5.0521
IKIK,IKIKIKIKIKIK,50.0,8.9000,μM,12,5.0506
LL-III/17,VNWRRILGRIIRVVR,50.0,9.0000,μM,15,5.0458
PenShufLeu,RWFKIQLQIRRWKNKK,50.0,9.0000,μM,16,5.0458
LL-1,FLGALWKALSKLL,50.0,9.0000,μM,13,5.0458
MAC1/21,GFGMALRLLRRVL,50.0,9.0000,μM,13,5.0458
[Ala16] Ascaphin-8,GFKDLLKGAAKALVKAVLF,50.0,9.0000,μM,19,5.0458
Z9,AAWKWAWAKKWAKAKKWAKAA,50.0,9.0000,μM,21,5.0458
HAL-1/9,GMWSKILGKLIR,50.0,9.0000,μM,12,5.0458
LL-III/10,KNWKKILGKIIKVVK,50.0,9.0000,μM,15,5.0458
HAL-1/5,GMWKKILGHLIR,50.0,9.0000,μM,12,5.0458
Decoralin [AC1],RLLRLIRKLII,50.0,9.0000,μM,11,5.0458
MAC1/3,LFGMALKLLKKVL,50.0,9.0000,μM,13,5.0458
Temporin-1CEa LK2(6)A(L),FVKLKKILNIINSIFKK,50.0,9.0100,μM,17,5.0453
Lynronne-3,NRFTARFRRTPWRLCLQFRQ,50.0,9.2000,μM,20,5.0362
maximin 4,GIGGVLLSAGKAALKGLAKVLAEKYAN,50.0,9.2600,μM,27,5.0334
AmphiArc2 Off2.6,QIFKKVKTWYKKAFQILGRL,50.0,9.3000,μM,20,5.0315
P3,KWKLFKKIGIGAFLHSAKKF,50.0,9.3000,μM,20,5.0315
DIM-LF11-318,FWQRRIRRWRRFWQRRIRRWRR,50.0,9.3000,μM,22,5.0315
GL-22,GLWNSIKIAGKKLFVNVLDKIR,50.0,9.3600,μM,22,5.0287
Temporin-1CEa LK2(6)AN(2L),FVKLKKILNIILSIFKK,50.0,9.3900,μM,17,5.0273
Tritrp-Arg,VRRFPWWWPFLRR,50.0,9.4000,μM,13,5.0269
I-11,VRRFRLFFRRLRRSV,50.0,9.4600,μM,15,5.0241
maximin4,GIGVLLSAGKAALKGLAKVLAEKYAN,50.0,9.4700,μM,26,5.0237
Indolicidin-Lys,ILPWKWPWWPWKK,50.0,9.5000,μM,13,5.0223
"Phylloseptin-PHa [A7K, A8I, V12I, A16I]",FLSLIPKIISAISALINHF,50.0,9.5470,μM,19,5.0201
"Cliotides T19, CT19",GSVIKCGESCLLGKCYTPGCTCSRPICKKD,50.0,9.5900,μM,30,5.0182
"Longicalycinin A analogue, cyclo-[Val-Thr-Pro-Phe-Leu]",VTPFL,50.0,9.6900,μM,5,5.0137
Dermaseptin S4 [M4K][N20K],ALWKTLLKKVLKAAAKAALKAVLVGANA,50.0,9.7600,μM,28,5.0106
Kalata B1 [W23WW],GLPVCGETCVGGTCNTPGCTCSWWPVCTRN,50.0,9.8000,μM,30,5.0088
PE-BBI,GALKGCWTKSIPPKPCK,50.0,9.8000,μM,17,5.0088
I-1,VKRFKKFFRKLKKSVL,50.0,9.8000,μM,16,5.0088
Chassatide C1,GDACGETCFTGICFTAGCSCNPWPTCTRN,50.0,9.8000,μM,29,5.0088
Chassatide C4,GASCGETCFTGICFTAGCSCNPWPTCTRN,50.0,9.8000,μM,29,5.0088
Dermaseptin S4 [M4K],ALWKTLLKKVLKAAAKAALNAVLVGANA,50.0,9.8700,μM,28,5.0057
Citropin retro,LGGIVSAVKKIVDFLG,50.0,10.0000,μM,16,5.0
"[Lys15, Lys16] XT-7",GLLGPLLKIAAKVGKKLL,50.0,10.0000,μM,18,5.0
PsT-1,KPPPWVPV,50.0,~10.0000,μM,8,5.0
MSI-136,GIGKFLKKAKKFAKAFVKIINN,50.0,10.0000,μM,22,5.0
Pep27anal2,MWKWFHNVLSWWWLLADKRPARDYNRK,50.0,<10.0000,μM,27,5.0
Citropin 11,GLFDVIKKVASVIKGL,50.0,10.0000,μM,16,5.0
Decoralin [AT1],LLLQLIRKLIL,50.0,10.0000,μM,11,5.0
Citropin 23,GLFKVIKKVAKVIKKL,50.0,10.0000,μM,16,5.0
Citropin 22,GLFKVIKKVASVIGGL,50.0,10.0000,μM,16,5.0
LfcinB,FKCRRWQWRMKK,50.0,10.0000,μM,12,5.0
Aurein 3.3,GLFDIVKKIAGHIVSSI,50.0,10.0000,μM,17,5.0
Citropin 7,GLFDVIKKVAAVIGGL,50.0,10.0000,μM,16,5.0
MAC1,GFGMALKLLKKVL,50.0,10.0000,μM,13,5.0
Aurein1.2,GLFDIIKKIAESF,50.0,10.0000,μM,13,5.0
Aurein2.6,GLFDIAKKVIGVIGSL,50.0,10.0000,μM,16,5.0
Citropin 14,GLFDVIAKVASVIKKL,50.0,10.0000,μM,16,5.0
Citropin 13,GLFDVIKKVASVIKKL,50.0,10.0000,μM,16,5.0
AmphiArc2 Off2,HIIKKIRTWYRKAWHVLGKV,50.0,10.0000,μM,20,5.0
PuroA-Lys,FPVTWKWWKWWKG,50.0,10.0000,μM,13,5.0
"[Ser18,Ser24]-brevinin-1BYa",FLPILASLAAKFGPKLFSLVTKKS,50.0,10.0000,μM,24,5.0
MB30,GQVWEATATVNAIRGSVTPAVSQFNARTAD,50.0,~10.0000,μM,30,5.0
AmphiArc2 Off3,KLYKKFRHILKKVWHYVGKI,50.0,10.0000,μM,20,5.0
Citropin 17,GLFAVIKKVAAVIKKL,50.0,10.0000,μM,16,5.0
Citropin 18,GLFAVIKKVAAVIRRL,50.0,10.0000,μM,16,5.0
Aurein2.5,GLFDIVKKVVGAFGSL,50.0,10.0000,μM,16,5.0
Citropin 16,GLFAVIKKVASVIKKL,50.0,10.0000,μM,16,5.0
Citropin 15,GLFAVIKKVASVIKGL,50.0,10.0000,μM,16,5.0
Aurein 3.1,GLFDIVKKIAGHIAGSI,50.0,10.0000,μM,17,5.0
Aurein 3.2,GLFDIVKKIAGHIASSI,50.0,10.0000,μM,17,5.0
PMAP-23 [R10W][Q13W][K14W],RIIDLLWRVWRPWWPKFVTVWVR,50.0,10.0000,μM,23,5.0
IDP-wtL05,RKRRNDLRSRFLALRDQ,50.0,~10.0000,μM,17,5.0
HYL,GIMSSLMKKLAAHIAK,50.0,10.0100,μM,16,4.9996
GK-2,KWKLFKKIGIGRLLKRGLRKLLKLLR,50.0,10.0753,μM,26,4.9967
FLAK03 AM,FALALKALKKLLKKLKKLAKKAL,50.0,10.0800,μM,23,4.9965
B18I,GIGKAIAKAIACIAKAIA,50.0,10.1000,μM,18,4.9957
KilerFLIP-E,YGRKKRRQRRRREADFFWSLCTA,92.3,20.0000,μM,23,4.9937
Granulysin (23-51),QRSVSNAATRVCRTGRSRWRDVCRNFMRR,90.0,20.0000,μM,29,4.9921
cPep2,FFGSVLKLIPKIL,89.36941,~20.0000,μM,13,4.9916
Longicalycinin A cyclic analogue 11 linear,TVPFA,50.0,10.2000,μM,5,4.9914
I-2,VKRFKKFFRKLKKSVLL,50.0,10.2000,μM,17,4.9914
SHIVA 10 (1-16),KTKLFKKFAKKLAKKLKKLAKKL,50.0,10.2500,μM,23,4.9893
"[R4A,R18A]cGm",GCRALCYKQRCVTYCRGA,50.0,10.3000,μM,18,4.9872
AmphiArc2 Off2.5,KIFKKFKDWFKKAFHVLGKV,50.0,10.4000,μM,20,4.983
R-DIM-P-LF11-322,PFWRIRIRRPRRIRIRWFP,50.0,10.4000,μM,19,4.983
LK,LKKLLKLLKKLLKL,80.0,20.0000,μM,14,4.9789
Figainin 1,FIGTLIPLALGALTKLFK,50.0,10.5000,μM,18,4.9788
P144,TSLDASIWAMMQNA,50.0,10.6200,μM,14,4.9739
6,FLGPTIGKIAKFILKHIVGLGDAALV,50.0,10.7000,μM,26,4.9706
I-4,VRRFRRFFRRLRRSV,50.0,10.7000,μM,15,4.9706
"Phylloseptin-PHa [A7K, V12I, A16I]",FLSLIPKAISAISALINHF,50.0,10.8500,μM,19,4.9646
Pleurocidin KR,GWGSFFRRAAHVGRHVGRAALTHYL,50.0,10.8743,μM,25,4.9636
"Longicalycinin A analogue, cyclo-[Val-Tyr-Pro-Ile-Ala]",VYPIA,50.0,10.8800,μM,5,4.9634
AmphiArc2 Off2.2.8,QYLRRVRTWLRRAWHILGKV,50.0,11.0000,μM,20,4.9586
L6,PAWRKAFRWAARMLKKAA,50.0,11.0000,μM,18,4.9586
AmphiArc2 Off4,KYIRHLKTWFKKVFKLIGEV,50.0,11.0000,μM,20,4.9586
HAL-1,GMWSKILGHLIR,50.0,11.0000,μM,12,4.9586
L7,PAWRKAFRAAWRMLKKAA,50.0,11.0000,μM,18,4.9586
N-3,KWFKKIPKFLHLAKKF,50.0,11.0000,μM,16,4.9586
Brevinin-1Yb,FLPIIAGAAAKVVQKIFCAISKKC,50.0,11.0000,μM,24,4.9586
Decoralin [AC3],LLLLLIRKLIK,50.0,11.0000,μM,11,4.9586
SHIVA 11[(1-16)ME(2-9]-COOH,FAKKLAKKLKKLAKKLIGAVLKV,50.0,11.0400,μM,23,4.957
LL-37 (17-29) [V21L],FKRILQRIKDFLR,50.0,11.0800,μM,13,4.9555
HPRP-A1-GG-RGD,FKKLKKLFSKLWNWKGGRGD,50.0,11.1000,μM,20,4.9547
YALRAH,YALRAH,50.0,11.1000,μM,6,4.9547
From_Paper_9,FLPILGKILGGLL,50.0,11.1700,μM,13,4.9519
AmphiArc2 Off2.7,RLIKRIKTWYRKAWKVVGKF,50.0,11.2000,μM,20,4.9508
NRC-126,GWRKWIKKATHVGKHIGKAALDAYI,50.0,11.2300,μM,25,4.9496
2,GLGDFIKAIAKHLGPLIGILPSKLKVAA,50.0,11.3000,μM,28,4.9469
Tritrp-W7Y,VRRFPWYWPFLRR,50.0,11.4000,μM,13,4.9431
Tritrp-Lys,VKKFPWWWPFLKK,50.0,11.5000,μM,13,4.9393
ChBac3.4 (H-),RFRLPFRRPPIRIPPPFYPPFRRFL,50.0,11.5000,μM,25,4.9393
FLAK 56,FAKKLAKKLAKLL,50.0,11.5500,μM,13,4.9374
AmphiArc2 Off2.2,QIIKKIRTWYRKAWHVLGKV,50.0,11.6000,μM,20,4.9355
NRC-19,FLGLLFHGVHHVGKWIHGLIHGHH,50.0,11.6400,μM,24,4.934
LL-37(17-29),FKRIVQRIKDFLR,50.0,11.6900,μM,13,4.9322
NRC-127,GCKKWFKKAAHVGKNVGKVALNAYL,50.0,11.7200,μM,25,4.9311
HYL-13,GIMSSLMKKLAAHIAA,50.0,11.8400,μM,16,4.9266
AmphiArc2 Off8,RFLKHFKTVYKRYWKVLGRL,50.0,11.9000,μM,20,4.9245
AmphiArc2 Off6,HIFKKVKTYWKKLFRILGRF,50.0,12.0000,μM,20,4.9208
Temporin-CEa,FVDLKKIANIINSIF,50.0,12.0000,μM,15,4.9208
Latarcin-5,GFFGKMKEYFKKFGASFKRRFANLKKRL,50.0,12.0000,μM,28,4.9208
Tritrp-W8Y,VRRFPWWYPFLRR,50.0,12.0000,μM,13,4.9208
Brevinin-1BLa,FLPAIVGAAAKFLPKIFCAISKKC,50.0,12.0000,μM,24,4.9208
9R,RRRRRNWMWC,50.0,12.0000,μM,10,4.9208
L5b,PAWRKAFRWAWHMLHHAA,50.0,12.0000,μM,18,4.9208
[Lys4] Ascaphin-8,GFKKLLKGAAKALVKTVLF,50.0,12.0000,μM,19,4.9208
PuroA-Arg,FPVTWRWWRWWRG,50.0,12.0000,μM,13,4.9208
HAL-2,GKWMSLLKHILK,50.0,12.0000,μM,12,4.9208
L13,PAWRKAFRKAWRMLKKAA,50.0,12.0000,μM,18,4.9208
DRS B3,ALWKNMLKGIGKLAGQAALGAVKTLVGA,50.0,12.0000,μM,28,4.9208
Alyteserin-2a [T8W],ILGKLLSWAAGLLSNL,50.0,12.0000,μM,16,4.9208
From_Paper_11,INWKAILGKIGKAAAAVI,50.0,12.0600,μM,18,4.9187
FLAK50V,VAKLLAKLAKKLL,50.0,12.0700,μM,13,4.9183
maximin 5,SIGAKILGGVKTFFKGALKELASTYLQ,50.0,12.1100,μM,27,4.9169
Tritrp DiSu,CVRRFPWWYPFLRRC,50.0,12.3000,μM,15,4.9101
C7A-D21K,KILRGVAKKIMRTFLRRISKKILTGKK,50.0,12.3000,μM,27,4.9101
AmphiArc2 Off5,KIFKKFKDFLKKIFQYLGKV,50.0,12.4000,μM,20,4.9066
Tritrp-P59A,VRRFAWWWAFLRR,50.0,12.5000,μM,13,4.9031
Modifed Coco3,LARFVLRILKYGFK,50.0,12.5000,μM,14,4.9031
"Decoralin, Dec-NH2",SLLSLIRKLIT,50.0,12.5000,μM,11,4.9031
Pantinin-2,IFGAIWKGISSLL,50.0,12.5000,μM,13,4.9031
[Leu]11 -Dec-NH2,SLLSLIRKLLT,50.0,12.5000,μM,11,4.9031
Modifed Aper1,FKLVWKLLKKLALKL,50.0,12.5000,μM,15,4.9031
GK-1,KWKLFKKIGIGRLLKRGLRKLLK,50.0,12.5287,μM,23,4.9021
GA-K4,FLKWLFKWAKK,50.0,12.5500,μM,11,4.9014
tPep8,FIGMIPGLIGGLISAIK,63.56608,~20.0000,μM,17,4.9005
Figainin 2,FLGAILKIGHALAKTVLPMVTNAFKPKQ,50.0,12.8000,μM,28,4.8928
HPRP-A1-GG-iRGD,FKKLKKLFSKLWNWKGGCRGDKGPDC,50.0,12.9000,μM,26,4.8894
Alyteserin-2a [N15K],ILGKLLSTAAGLLSKL,50.0,13.0000,μM,16,4.8861
Decoralin [AC4],YLLYLIRKLIL,50.0,13.0000,μM,11,4.8861
AmphiArc2 Off2.2.9,QLLKKIRTWYRKAWHVYGKV,50.0,13.0000,μM,20,4.8861
HAL-2/13,GKWMTLLKHILK,50.0,13.0000,μM,12,4.8861
AmphiArc2 Off2.2.2,QLIHKIRTWYRKAWHVLGKV,50.0,13.0000,μM,20,4.8861
LL-III/27,VNWKKVLGKVVKVVK,50.0,13.0000,μM,15,4.8861
HAL-1/10,GMWKKILGKLIR,50.0,13.0000,μM,12,4.8861
C7A-Δ,KILRGVAKKIMRTFLRRILTGKK,50.0,13.1000,μM,23,4.8827
Kalata B1,GLPVCGETCVGGTCNTPGCTCSWPVCTRN,50.0,13.1000,μM,29,4.8827
GA-W4,FLWWLFKWAWK,50.0,13.1600,μM,11,4.8807
[F4S-Y13S]cTI,KWCSRVCYRGICSRRCRG,50.0,13.2000,μM,18,4.8794
FLAK51,FAKKLAKLALKLAKL,50.0,13.2800,μM,15,4.8768
Longicalycinin A cyclic analogue 14 linear,PYFFL,50.0,13.3000,μM,5,4.8761
RGD-Las,RGDLLRHVVKILSKYL,86.175,26.1700,μM,16,4.8717
I-10,VRRFRRFFLRLRRSV,50.0,13.5000,μM,15,4.8697
Pantinin-3,FLSTIWNGIKSLL,50.0,13.5000,μM,13,4.8697
From_Paper_10,FFPILGKLLSGIL,50.0,13.5300,μM,13,4.8687
PBP-W18,KKLIKVFAKGFKKAKKLWKGIG,52.0,15.0000,μM,22,4.8652
PBP-W11,KKLIKVFAKGWKKAKKLFKGIG,52.0,15.0000,μM,22,4.8652
Gaegurin-5,FLGALFKVASKVLPSVKCAITKKC,50.0,13.7000,μM,24,4.8633
Longicalycinin A cyclic analogue 9 linear,FYPFV,50.0,13.8885,μM,5,4.8573
GA-W3,FLGWLFKWAWK,50.0,13.9700,μM,11,4.8548
MRP,AIGSILGALAKGLPTLISWIKNR,50.0,14.0000,μM,23,4.8539
HAL-1/15,GMWSKLLGHLLR,50.0,14.0000,μM,12,4.8539
Brevinin-1Yc,FLPIIAGAAAKVVEKIFCAISKKC,50.0,14.0000,μM,24,4.8539
HAL-2/11,GKWLSLLKHILK,50.0,14.0000,μM,12,4.8539
Decoralin [AC5],RLLRLIRKLIR,50.0,14.0000,μM,11,4.8539
HAL-2/18,GKWMSLLKHIWK,50.0,14.0000,μM,12,4.8539
[Lys5] XT-7,GLLGKLLKIAAKVGSNLL,50.0,14.0000,μM,18,4.8539
HAL-2/1,GKWKSLLKHILK,50.0,14.0000,μM,12,4.8539
L6A,KWKSFAKTFKSAKKTVLHTALKAISS,50.0,14.0000,μM,26,4.8539
Z8,AWKKWAKAWKWAKAKWWAKAA,50.0,14.0000,μM,21,4.8539
RGD-La,RGDLLRHVVKILEKYL,73.09,25.6100,μM,16,4.8515
LvHemB1,DVNFLLHKIYGNIRY,78.44,26.8100,μM,15,4.8482
MAD1,KRWHWWRRHWVVW,50.0,14.2000,μM,13,4.8477
HPRP-A1-iRGD,FKKLKKLFSKLWNWKCRGDKGPDC,50.0,14.3000,μM,24,4.8447
Longicalycinin A cyclic analogue 2 linear,LYPFA,50.0,14.3700,μM,5,4.8425
peptide1,FLSGIVGMLGKLF,50.0,14.4700,μM,13,4.8395
B1-Gln,VKRFKKFFRKLKKQV,50.0,14.5000,μM,15,4.8386
Tritrp-P59A-Lys,VKKFAWWWAFLKK,50.0,14.5000,μM,13,4.8386
IKIR,IKIRIKIRIKIR,50.0,14.5000,μM,12,4.8386
LKLK,LKLKLKLKLKLK,50.0,14.5000,μM,12,4.8386
Anubis-2,FAKKLAKKLKKLAKKLAKLAKKL,50.0,14.5600,μM,23,4.8368
Longicalycinin A linear,FYPFG,50.0,14.5784,μM,5,4.8363
cPep3,GFFDLAKKVVGGIRNALGI,57.67094,~20.0000,μM,19,4.8344
NRC-16,GWKKWLRKGAKHLGQAAIK,50.0,14.7000,μM,19,4.8327
B1-Gly,VKRFKKFFRKLKKGV,50.0,14.8000,μM,15,4.8297
m2163,KRKCPKTPFDNTPGAWFAHLILGC,50.0,14.8100,μM,24,4.8294
FLAK 17 CV,VAKALKALLKALKAL,50.0,14.8300,μM,15,4.8289
m2386,DSIRDVSPTFNKIRRWFDGLFK,50.0,14.8300,μM,22,4.8289
TRPs P1,RKRWWRWWKWWKR,50.0,14.9200,μM,13,4.8262
Z7,KAAKKAWKAAKKAWKAAKKAA,50.0,15.0000,μM,21,4.8239
G-V,GIIKKIIKKIIKKV,50.0,15.0000,μM,14,4.8239
"FR8, 11P",FRRFFKWPRRPFKFF,50.0,15.0000,μM,15,4.8239
Cationic Amphiphilic,GIIKKIIIKKIIIKKI,50.0,15.0000,μM,16,4.8239
V-I,VIIKKIIKKIIKKI,50.0,15.0000,μM,14,4.8239
HAL-1/6,GMWSKILGHLIK,50.0,15.0000,μM,12,4.8239
mt_E17L/L22 W/P27A,LTFSDWWKLLAE,50.0,15.1000,μM,12,4.821
Tritrp-P9A-Lys,VKKFPWWWAFLKK,50.0,15.1000,μM,13,4.821
HYL-8,GIMSSLMAKLAAHIAK,50.0,15.1700,μM,16,4.819
I-8,VKRFKKFFLKLKSV,50.0,15.4000,μM,14,4.8125
"Longicalycinin A analogue, cyclo-[Pro-Tyr-Val-Phe-Ala]",PYVFA,50.0,15.4600,μM,5,4.8108
Lactoferricin B,FKCRRWQWRMKKLGA,50.0,15.5000,μM,15,4.8097
IRIK,IRIKIRIKIRIK,50.0,15.5000,μM,12,4.8097
Lactoferricin B,FKCRRWQWRMKKLGAPSITCVRRAF,50.0,15.5000,μM,25,4.8097
Shiva-11,FAKKLAKKLKKLAKKLAKLALALKALALKAL,50.0,15.5400,μM,31,4.8085
Temporin-1CEa LK2(6),FVKLKKIANIINSIFKK,50.0,15.5400,μM,17,4.8085
LR-13,CLLRRLLRRLLRR,50.0,15.6000,μM,13,4.8069
L21A,KWKSFLKTFKSAKKTVLHTAAKAISS,50.0,15.6000,μM,26,4.8069
L21A,KWKSFLKTFKSAKKTVAHTAAKAISS,50.0,15.6000,μM,26,4.8069
DPS3,ALWKDILKNAGKAALNEINQIVQ,50.0,15.6700,μM,23,4.8049
"Longicalycinin A analogue, cyclo-[Phe-Tyr-Pro-Val-Gly]",FYPVG,50.0,15.6793,μM,5,4.8047
B1,KKLFKKILKYLK,50.0,15.7000,μM,12,4.8041
CA-MA,KWKLFKKIGIGKFLHSAKKF,50.0,15.8000,μM,20,4.8013
Ped4,FLWSRILFRLRK,50.0,15.8500,μM,12,4.8
PTN,ILGTILGLLKGL,50.0,15.9000,μM,12,4.7986
"Longicalycinin A analogue, cyclo-[Phe-Tyr-Pro-Phe-Ala]",FYPFA,50.0,15.9694,μM,5,4.7967
MAC1/2,AFGMALKLLKKVL,50.0,16.0000,μM,13,4.7959
Z6,KWWKKAAKAAKKAAKAAKKWA,50.0,16.0000,μM,21,4.7959
PMAP-23 [R10W][Q13W],RIIDLLWRVWRPWKPKFVTVWVR,50.0,16.0000,μM,23,4.7959
Dermaseptin S4 (1-16)[M4K],ALWKTLLKKVLKAAAK,50.0,16.0000,μM,16,4.7959
Decoralin [AC8],MLLMLIRKLIL,50.0,16.0000,μM,11,4.7959
Brevinin-1Ya,FLPVIAGVAANFLPKLFCAISKKC,50.0,16.0000,μM,24,4.7959
HAL-2/19,GKWMSLLKHWLK,50.0,16.0000,μM,12,4.7959
Decoralin [AT2],TLLLLIRKLIL,50.0,16.0000,μM,11,4.7959
AmphiArc2 Off2.2.5,QLLKKVRTWYRKAWHLYGKV,50.0,16.0000,μM,20,4.7959
L4,PAWFKARRWAWRMLKKAA,50.0,16.0000,μM,18,4.7959
R-DIM-LF11-316,RWKRINRQWFFWQRNIRKWR,50.0,16.0000,μM,20,4.7959
"Cyclo(Pro-Leu), S.sp. DKP-PL, Gancidin W",PL,55.0,20.0000,μM,2,4.7941
Unknown,QIWHKIRKLWQIIKDGF,50.0,16.1000,μM,17,4.7932
Tritrp-P5A,VRRFAWWWPFLRR,50.0,16.2000,μM,13,4.7905
D2A21,FAKKFAKKFKKFAKKFAKFAFAF,50.0,16.2100,μM,23,4.7902
Longicalycinin A cyclic analogue 15 linear,PYGFV,50.0,16.2300,μM,5,4.7897
Longicalycinin A cyclic analogue 5 linear,FSPFG,50.0,16.2389,μM,5,4.7894
FLAK50B,FAKALAKLAKKLL,50.0,16.2600,μM,13,4.7889
mt_L22 W/P27A,ETFSDWWKLLAE,50.0,16.3000,μM,12,4.7878
L17A,KWKSFLKTFKSAKKTVAHTALKAISS,50.0,16.4000,μM,26,4.7852
Longicalycinin A cyclic analogue 17 linear,FSPFA,50.0,16.4368,μM,5,4.7842
I-9,VKRFKLFFRKLKSV,50.0,16.5000,μM,14,4.7825
Longicalycinin A cyclic analogue 12 linear,FYPFI,50.0,16.5060,μM,5,4.7824
Temporin-SHe,FLPALAGIAGLLGKIF,45.0,12.5000,μM,16,4.7811
tPep15,GLVDVLGKVGGLIKKLLPG,54.18136,~20.0000,μM,19,4.7803
Longicalycinin A cyclic analogue 1 linear,GYPFV,50.0,16.6100,μM,5,4.7796
IL4RPep1KLA,CRKRLDRCGGGKLAKLAKKLAKLAK,50.0,16.6100,μM,25,4.7796
MagaininF5W-Lys,GIGKWLHSAKKFGKAFVGEIMNS,50.0,16.8000,μM,23,4.7747
MagaininF5W-Arg,GIGRWLHSARRFGRAFVGEIMNS,50.0,16.8000,μM,23,4.7747
AmphiArc2 Off2.2.10,QIYKKYRTWYRKAWKVLGKV,50.0,16.9000,μM,20,4.7721
PTP8,FLKLLAGLLKNFA,50.0,16.9800,μM,13,4.7701
ChBac3.4 (12-26),RIHPPPFYPPFRRFL,50.0,17.0000,μM,15,4.7696
GW-H1,GYNYAKKLANLAKKFANALW,50.0,17.0000,μM,20,4.7696
PenShuf,RWFKIQMQIRRWKNKK,50.0,17.0000,μM,16,4.7696
B1-Thr,VKRFKKFFRKLKKTV,50.0,17.0000,μM,15,4.7696
"Longicalycinin A analogue, cyclo-[Phe-Thr-Pro-Phe-Val]",FTPFV,50.0,17.0573,μM,5,4.7681
From_Paper_110,NFWLSTLTGHGFCAVVSAARAGS,59.9,25.0000,μM,23,4.7659
"Longicalycinin A analogue, cyclo-[Gly-Tyr-Pro-Phe-Ala]",GYPFA,50.0,17.1600,μM,5,4.7655
Longicalycinin A cyclic analogue 4 linear,AYPFG,50.0,17.2143,μM,5,4.7641
BmKn-2,FIGAIARLLSKIF,50.0,17.9500,μM,13,4.7459
Ltc-2a [I7Q],GLFGKLQKKFGRKAISYAVKKARGKH,50.0,18.0000,μM,26,4.7447
Decoralin [AT3],RLLLLIRKLIL,50.0,18.0000,μM,11,4.7447
Ltc-2a [F10K],GLFGKLIKKKGRKAISYAVKKARGKH,50.0,18.0000,μM,26,4.7447
L3,PAWRKAFRWAWRMKKLAA,50.0,18.0000,μM,18,4.7447
LL-37 (17-29) [F17A],AKRIVQRIKDFLR,50.0,18.1400,μM,13,4.7414
"K5, 17-DPS3",ALWKKILKNAGKAALNKINQIVQ,50.0,18.2000,μM,23,4.7399
LHH1,AFALIAGALYRIFHRR,50.0,18.2700,μM,16,4.7383
B6,LKKLFKKILKYLKK,50.0,18.4000,μM,14,4.7352
BPC94,KLLKKFKKLQ,50.0,18.5000,μM,10,4.7328
TG23,TAGIKLTVPIEKFPVTTQTFWG,40.0,~10.0000,μM,22,4.7307
Temporin-1CEa LK1,FVDLKKIANIINSIFKK,50.0,18.7000,μM,17,4.7282
FLAK 17 C,FAKALKALLKALKAL,50.0,18.7600,μM,15,4.7268
HDH-LGBP-A1,WLWKAIWKLLT,35.0,6.8600,μM,11,4.7258
AmphiArc2 Off9,KLIHRLKTVFKKVWHFLGHL,50.0,18.9000,μM,20,4.7235
"Longicalycinin A analogue, cyclo-[Phe-Ser-Pro-Ala-Gly]",FSPAG,50.0,18.9734,μM,5,4.7219
Gradient2,AWLKRIKKFLKALFWVWVW,50.0,19.0000,μM,19,4.7212
PMAP-23 [R10W],RIIDLLWRVWRPQKPKFVTVWVR,50.0,19.0000,μM,23,4.7212
YALPAR,YALPAR,50.0,19.0000,μM,6,4.7212
L5a,PAWHHAFHWAWRMLKKAA,50.0,19.0000,μM,18,4.7212
FLAK 50O,FAKLLAKALKKAL,50.0,19.0800,μM,13,4.7194
Lynronne-1,LPRRNRWSKIWKKVVTVFS,50.0,19.1200,μM,19,4.7185
HS1,CGAISLAPKAQIKES,50.0,19.2000,μM,15,4.7167
FLAK50 Q7,FAKLLAKALKKFAL,50.0,19.2100,μM,14,4.7165
Tritrp-W6Y,VRRFPYWWPFLRR,50.0,19.3000,μM,13,4.7144
H193W,GCRLYGFKIWGG,50.0,19.4000,μM,12,4.7122
HYL-1,AIMSSLMKKLAAHIAK,50.0,19.7200,μM,16,4.7051
LL-37 KR-12,KRIVQRIKDFLR,50.0,19.8500,μM,12,4.7022
B1-Asp,VKRFKKFFRKLKKDV,50.0,19.9000,μM,15,4.7011
SALF,ECKFTVKPYLKRFQVYYKGRMWCP,65.0,32.5600,μM,24,4.7009
PMAP-23 [Q13W],RIIDLLWRVRRPWKPKFVTVWVR,50.0,20.0000,μM,23,4.699
L10,PAARKAFRWAWRMLKKAA,50.0,20.0000,μM,18,4.699
Granulysin (37-51),GRSRWRDVCRNFMRR,50.0,20.0000,μM,15,4.699
Ranatuerin-2Ya,GLMDTIKGVAKTVAASWLDKLKCKITGC,50.0,20.0000,μM,28,4.699
CRAMP-18[E2K],GKKLKKIGQKIKNFFQKL,50.0,20.0000,μM,18,4.699
Alyteserin-2a [G11K],ILGKLLSTAAKLLSNL,50.0,20.0000,μM,16,4.699
"Alyteserin-2a [S7K, G11K]",ILGKLLKTAAKLLSNL,50.0,20.0000,μM,16,4.699
CA-MA2,KWKLFKKIPKFLHSAKKF,50.0,20.0000,μM,18,4.699
K-I,KIIKKIIKKIIKKI,50.0,20.0000,μM,14,4.699
Ascaphin-8,GFKDLLKGAAKALVKTVLF,50.0,20.0000,μM,19,4.699
CIGB-300 (P15-Tat),CWMSPRHLGTCGRKKRRQRRRPPQ,50.0,20.0000,μM,24,4.699
LL-37 (17-29) [F17L],LKRIVQRIKDFLR,50.0,20.0000,μM,13,4.699
"Ixosin [H3A,E8K,E13L,S16V], Ixosin-pch-H3A",GLAKVMRKVLGYLRNVYK,28.0,~4.0000,μM,18,4.6979
I192F,GCRLYGFKFHGCG,50.0,20.1000,μM,13,4.6968
Not available,KGWFKAMKSIAKFIAKEKLKEHL,97.0,40.0000,μM,23,4.695
Not available,RKGWFKAMKSIAKFIAKEKLKEHL,97.0,40.0000,μM,24,4.695
Not available,WFKAMKSIAKFIAKEKLK,97.0,40.0000,μM,18,4.695
Not available,KGWFKAMKSIAKFIAKEKMKEHL,97.0,40.0000,μM,23,4.695
Brevinin1 HYba1 AMD,FFPGIIKVASAILPTAICAITKRC,85.0,39.4600,μM,24,4.692
Brevinin1 HYba2 AMD,FFPGIIKVAGAILPTAICAITKRC,90.0,39.9300,μM,24,4.6918
"sC18 [R10F,E15Del,K16F]",GLRKRLRKFFNKIKF,90.0,<40.0000,μM,15,4.6911
Granuliberin-SSa,FIFLPIFRRPVS,50.5,21.4500,μM,12,4.6793
LyeTxI-b,IWLTALKFLGKNLGKLAKQQLAKL,50.0,20.9400,μM,24,4.679
"sC18 [E15F,E15F,K16F]",GLRKRLRKFFNKIKFF,80.0,<40.0000,μM,16,4.6779
"sC18 [E15F,K16F]",GLRKRLRKFRNKIKFF,80.0,40.0000,μM,16,4.6779
Decoralin [AC6],QLLQLIRKLII,50.0,21.0000,μM,11,4.6778
Alyteserin-2a [A9W],ILGKLLSTWAGLLSNL,50.0,21.0000,μM,16,4.6778
C-6,KWKLFKKIPKFLHLA,50.0,21.0000,μM,15,4.6778
BP100 [Y10I],KKLFKKILKIL,50.0,21.3000,μM,11,4.6716
BP100 [Y10A],KKLFKKILKAL,50.0,21.4000,μM,11,4.6696
"sC18 [R10F,E15F]",GLEKRKRKFFNKIKFK,75.0,40.0000,μM,16,4.6647
RPS6 subunit anticancer peptide,ISGGNDKQGFPM,40.35,12.0000,μM,12,4.6626
Brevinin-Alb,FLPLAVSLAANFLPKLFCKITKKC,50.0,21.7500,μM,24,4.6625
Cyclotide mech-3,GLPTCGETCTLGKCNTPKCTCNWPICYKN,50.0,21.9400,μM,29,4.6588
Cyclotide mech-2,GLPTCGETCTLGKCNTPKCTCNWPICYKD,50.0,21.9400,μM,29,4.6588
IL-5,FKIGGFIKKLWRSLAA,50.0,22.0000,μM,16,4.6576
LL-1a,FLGALWHALSKLL,50.0,22.0000,μM,13,4.6576
[Lys16] XT-7,GLLGPLLKIAAKVGSKLL,50.0,22.0000,μM,18,4.6576
HAL-1/20,GKWSKILGKLIR,50.0,22.0000,μM,12,4.6576
B1,VKRFKKFFRKLKKSV,50.0,22.2000,μM,15,4.6536
NRC-12,GWKKWFNRAKKVGKTVGGLAVDHYL,50.0,22.3800,μM,25,4.6501
BPC88,KKLLKFKKLQ,50.0,22.5000,μM,10,4.6478
"FhHDM-1p2  (14-31) [E3K, I7K, D14K, R15K, E17S]",ITKVITKLLNRLTKILSK,50.0,22.5000,μM,18,4.6478
PLS-S2,FLSLIPHIVSGVASLAKHF,50.0,22.5000,μM,19,4.6478
BP105,LKLFKKILKYL,50.0,22.7000,μM,11,4.644
FLAK50 Z4,FAKLWAKLAFGKGIGKVGKKLL,50.0,22.7500,μM,22,4.643
Tritrp-W8A,VRRFPWWAPFLRR,50.0,22.8000,μM,13,4.6421
NRC-128,GIRKWFKKAAHVGKKVGKVALNAYL,50.0,22.9900,μM,25,4.6385
PMAP-23 [Q13W][K14W],RIIDLLWRVRRPWWPKFVTVWVR,50.0,23.0000,μM,23,4.6383
E-I,EIIKKIIKKIIKKI,50.0,23.0000,μM,14,4.6383
N-4,WFKKIPKFLHLAKKF,50.0,23.0000,μM,15,4.6383
C-2,KWKLFKKIPKFLHLAKK,50.0,23.0000,μM,17,4.6383
PLS-S4,FLSMIPHIVSGVAALAKHL,50.0,23.0000,μM,19,4.6383
PLS-S1,FLSLIPHIVSGVASIAKHF,50.0,23.0000,μM,19,4.6383
L-K6,IKKILSKIKKLLK,50.0,23.0000,μM,13,4.6383
HAL-2/6,GKWMSFLKHILK,50.0,23.0000,μM,12,4.6383
LK-13,CLLKKLLKKLLKK,50.0,23.0000,μM,13,4.6383
"Ixosin (4-18)[E8K,E13L,S16V], Ixosin-pch4–18",KVMRKVLGYLRNVYK,19.0,2.0000,μM,15,4.6346
"BP76, Cecropin A (2-8)[W2K] + Melittin (6-9)[V8F]",KKLFKKILKFL,50.0,23.5000,μM,11,4.6289
Gaegurin 5 (1-11)[A4W],FLGWLFKVASK,50.0,23.5300,μM,11,4.6284
Decoralin [AC7],QLLQLIRKLIM,50.0,24.0000,μM,11,4.6198
[Lys15] XT-7,GLLGPLLKIAAKVGKNLL,50.0,24.0000,μM,18,4.6198
"Tritrpticin [P5,9K]",VRRFKWWWKFLRR,50.0,24.0000,μM,13,4.6198
Phylloseptin-PHa,FLSLIPAAISAVSALANHF,50.0,24.0500,μM,19,4.6189
BP81,LKLFKKILKFL,50.0,24.2000,μM,11,4.6162
GW-Q6,GIKIAKKAITIAKKIAKIYW,50.0,24.3000,μM,20,4.6144
PL-D 1,WKWLKKWIK,50.0,24.3000,μM,9,4.6144
BPC184,KLLLKFKKLQ,50.0,24.5000,μM,10,4.6108
BPC96,LKLKKFKKLQ,50.0,24.5000,μM,10,4.6108
Tritrp-W678F,VRRFPFFFPFLRR,50.0,24.6000,μM,13,4.6091
GA-K3,FLGWLFKWAKK,50.0,24.7600,μM,11,4.6062
Z44,ALSKALSKALSKALSKALSKALSK,50.0,24.8500,μM,24,4.6047
KAL V,VALALKALKKALKKLKKALKKAL,50.0,24.9100,μM,23,4.6036
A-I,AIIKKIIKKIIKKI,50.0,25.0000,μM,14,4.6021
[Pro]4 -Dec-NH2,SLLPLIRKLIT,50.0,25.0000,μM,11,4.6021
C-4,KWKLFKKIPKFLHLAK,50.0,25.0000,μM,16,4.6021
LL-37(17-32)b,FKRIVQRIKDFLRNLV,50.0,25.0000,μM,16,4.6021
[Trp]11 -Dec-NH2,SLLSLIRKLIW,50.0,25.0000,μM,11,4.6021
Temporin-1OLa,FLPFLKSILGKIL,50.0,25.0000,μM,13,4.6021
Decoralin [AT4],LLLLLIRKLIL,50.0,25.0000,μM,11,4.6021
"Lavracin [D2G,P3K,Y4F]",WGKFFAGVKKLTKAILAVRA,50.0,25.0000,μM,20,4.6021
"Lavracin [D2G,P3K,Y4F,A17G,V18E,R19I]",WGKFFAGVKKLTKAILGEIA,50.0,25.0000,μM,20,4.6021
Temporin-1CEa LK3,FKKLKKIANIINSIFKK,50.0,25.0400,μM,17,4.6014
S1,KKWRKWLAK,99.0,50.0000,μM,9,4.5988
"LL-37 (13-32)[I13G,G14I]",GIKEFKRIVQRIKDFLRNLV,50.0,25.2000,μM,20,4.5986
PL-D 2,ILRWKWRWWRWRR,50.0,25.2000,μM,13,4.5986
BP100,KKLFKKILKYL,50.0,25.3000,μM,11,4.5969
B3,KKLFKKILKYLKKL,50.0,25.3000,μM,14,4.5969
"AamAP-S1, AamAP1 [H8K]",FLFSLIPKAIGGLISAFK,50.0,25.5800,μM,18,4.5921
Tritrp-W78Y,VRRFPWYYPFLRR,50.0,25.6000,μM,13,4.5918
GN-4,RWKKWWRWL,50.0,25.6100,μM,9,4.5916
Pentadactylin,GLLDTLKGAAKNVVGSLASKVMEKL,50.0,25.7000,μM,25,4.5901
C-1,KWKLFKKIPFLHLAKKF,50.0,26.0000,μM,17,4.585
Psyle A,GIACGESCVFLGCFIPGCSCKSKVCYFN,50.0,26.0000,μM,28,4.585
FLAK95,FALKALKKLKKALKKAL,50.0,26.1400,μM,17,4.5827
N29N,PDEDAINNALNKVCSTGRRQRSICKQLLKK,80.0,<50.0000,μM,30,4.581
G(VVKK)3V-NH2,GVVKKVVKKVVKKV,80.0,<50.0000,μM,14,4.581
G(LLKK)3L-NH2,GLLKKLLKKLLKKL,80.0,<50.0000,μM,14,4.581
TAT-Ras-GAP317-326,GRKKRRQRRRGGWMWVTNLRTD,79.0,50.0000,μM,22,4.5788
B5,LKKLFKKILKYLK,50.0,26.5000,μM,13,4.5768
Unknown,LPIP,50.0,26.6000,μM,4,4.5751
FLAK82,FAKKLAKKLL,50.0,26.7400,μM,10,4.5728
H193F,GCRLYGFKIFGCG,50.0,26.8000,μM,13,4.5719
(HHPHG)2,HHPHGHHPHG,50.0,26.9000,μM,10,4.5702
mt_T18S/L22 W/P27A,ESFSDWWKLLAE,50.0,27.0000,μM,12,4.5686
LL-37 (17-29) [F27L]-Ac,FKRIVQRIKDLLR,50.0,27.0000,μM,13,4.5686
NRC-15,GFWGKLFKLGLHGIGLLHLHL,50.0,27.1500,μM,21,4.5662
AmphiArc2 Off1,RVFKKFHPIYHRVWRLWGHL,50.0,27.4000,μM,20,4.5622
FLAK93B,KWKLAKKALALL,50.0,27.4800,μM,12,4.561
Tritrp-P5A-Lys,VKKFAWWWPFLKK,50.0,27.6000,μM,13,4.5591
ZXR-1,FKIGGFIKKLWRSKLA,50.0,27.9000,μM,16,4.5544
Z5,KAAKKAWKWAKKAAKWAKKAA,50.0,28.0000,μM,21,4.5528
PTP-7a,FLGALFHALSKLL,50.0,28.0000,μM,13,4.5528
ChBac3.4 (1-19)-NH2,RFRLPFRRPPIRIHPPPFY,50.0,28.0000,μM,19,4.5528
HYL-7,GIMSSLAKKLAAHIAK,50.0,28.3200,μM,16,4.5479
Pantinin-1,GILGKLWEGFKSIV,50.0,28.5000,μM,14,4.5452
AmphiArc2 Off2.10,QRIRQLHTWIKKAWHIWPKI,50.0,28.6000,μM,20,4.5436
CA-ME,KWKLFKKIGIGAVLKVLTTG,50.0,28.6000,μM,20,4.5436
SFTI-polyR-L1,CRRKRRRICFPDGR,50.0,28.7200,μM,14,4.5418
Z24,AKSKAKSKAKSKAKSKAKSKAKSK,50.0,28.7400,μM,24,4.5415
GW-A5,GATYAKKIIKTITKIATTAW,50.0,28.9000,μM,20,4.5391
HYL-3,GIASSLMKKLAAHIAK,50.0,28.9700,μM,16,4.5381
IK-13,CIIKKIIKKIIKK,50.0,29.0000,μM,13,4.5376
Decoralin [AC11],QLLQLIRKLIY,50.0,29.0000,μM,11,4.5376
Pep27anal4,MWKEFHNVLSSGQLLADKRWARWYNRW,50.0,29.0000,μM,27,4.5376
PMAP-23 [K14W],RIIDLLWRVRRPQWPKFVTVWVR,50.0,29.0000,μM,23,4.5376
Bax-BH3,DASTKKLSECLRRIGDELDS,62.0,44.7100,μM,20,4.5363
Lycosin-II,VWLSALKFIGKHLAKHQLSKL,50.0,29.2800,μM,21,4.5334
DM3,GLFDIWKWWRWRR,50.0,29.3900,μM,13,4.5318
Temporin-La,LLRHVVKILEKYL,50.9,30.7900,μM,13,4.5307
BPC194,KKLKKFKKLQ,50.0,29.5000,μM,10,4.5302
FLAK50F,FAKLLAKLAKKL,50.0,29.7700,μM,12,4.5262
Cyclopeptide GG-8-6 [L5A],VLPIALLVL,50.0,29.8000,μM,9,4.5258
GW-Q4,GANAAKKFATIAKKFINYLW,50.0,29.9000,μM,20,4.5243
Cyclopeptide GG-8-6 [V1A],ALPILLLVL,50.0,29.9400,μM,9,4.5237
SMAP-29,RGLRRLGRKIAHGVKKYGPTVLRIIRIA,50.0,30.0000,μM,28,4.5229
"LL-37 (15-32)[E1G], GF-17",GFKRIVQRIKDFLRNLV,50.0,30.0000,μM,17,4.5229
Ranatuerin-2VLb,GIMDTIKGAAKDLAGQLLDKLKCKITKC,50.0,30.0000,μM,28,4.5229
KW5,KAAKKAAKAAKKAAKAAKKAA,50.0,30.0000,μM,21,4.5229
P5317-28,QETFSDLWKLLP,50.0,30.0000,μM,12,4.5229
HAL-2/20,GKWMSLWKHILK,50.0,30.0000,μM,12,4.5229
Alyteserin-2a [S14K],ILGKLLSTAAGLLKNL,50.0,30.0000,μM,16,4.5229
C-8,KWKLFKKIPKFLHL,50.0,30.0000,μM,14,4.5229
Coccinin,KQTENLADTY,50.0,30.0000,μM,10,4.5229
HAL-1/21,GKWKKILGKLIR,50.0,30.0000,μM,12,4.5229
BP100 [Y10G],KKLFKKILKGL,50.0,30.3000,μM,11,4.5186
Pc,GCRLYGFKIHGCG,50.0,30.4000,μM,13,4.5171
HIV-TAT48-57,GRKKRRQRRR,65.0,50.0000,μM,10,4.5146
B9,KLKKLFKKILKY,50.0,30.6000,μM,12,4.5143
Temporin-Las,LLRHVVKILSKYL,50.64,31.6100,μM,13,4.5139
B2,KKLFKKILKYLKK,50.0,30.8000,μM,13,4.5114
GW-Q3,GANLAKKFYTYINKFINYAW,50.0,30.8000,μM,20,4.5114
peptide 1,KKWWKKWWK,50.0,31.0000,μM,9,4.5086
LL-1b,FLGALWKALSHLL,50.0,31.0000,μM,13,4.5086
SEQ ID NO.1 of Patent CN113912739A,QRDMHSHRDFQPVLVALNSPLSGGMRDRG,90.0,61.0200,μM,29,4.5077
Temporin-1CEa,FVDLKKIANIINSIFGK,50.0,31.4800,μM,17,4.502
LRLR,LRLRLRLRLRLR,50.0,31.8000,μM,12,4.4976
Psychrophilin D (1),LW,50.0,31.8200,μM,2,4.4973
Cyclopeptide GG-8-6 [L7A],VLPILLAVL,50.0,31.8400,μM,9,4.497
GN-2,RWKRWWRWI,50.0,31.9100,μM,9,4.4961
FLAK50D V,VAKLLAKALKKLL,50.0,31.9400,μM,13,4.4957
PTP-7b,FLGALFKALSHLL,50.0,32.0000,μM,13,4.4949
"Leucocin A (18-35)[E3R;S6R;A7R;G8,16L;H10R;N14,17R;G18R]",WGRAFRRLVRRLARGLRR,50.0,32.0000,μM,18,4.4949
L9,PAWRKAARWAWRMLKKAA,50.0,32.0000,μM,18,4.4949
"Leucocin A (18-35)[G2,8,16L;E3R;S6R;A7R;H10R;N14,17R;G18R]",WLRAFRRLVRRLARGLRR,50.0,32.0000,μM,18,4.4949
MAC2,GTGLPMSERRKIMLMMR,50.0,32.0000,μM,17,4.4949
B1AW,FLPLLAGLAANFLPQIICKIARKC,50.0,32.1500,μM,24,4.4928
Tritrp-W67Y,VRRFPYYWPFLRR,50.0,32.2000,μM,13,4.4921
BP100 [Y10T],KKLFKKILKTL,50.0,32.2000,μM,11,4.4921
SHIVA 10 AC,FAKKLAKKLKKLAKKLAKLALAL,50.0,32.7100,μM,23,4.4853
PenShufLysLeu,KWFKIQLQIKKWKNKK,50.0,33.0000,μM,16,4.4815
FLAK50 Q3,FAKLLAKFLKKAL,50.0,33.5400,μM,13,4.4744
PGAa,GILSKLGKALKKAAKHAAKA,30.0,~8.0000,μM,20,4.4742
ChBac3.4 (1-14)-NH2,RFRLPFRRPPIRIH,50.0,33.6000,μM,14,4.4737
Phylloseptin-PHa [A7K],FLSLIPKAISAVSALANHF,50.0,33.6500,μM,19,4.473
FLAK04 AM V,VALALKALKKLAKKLKKLAKKAL,50.0,33.7400,μM,23,4.4719
Unknown,KVWKIKKNIRRLLHGIKRGWKG,50.0,34.0000,μM,22,4.4685
HAL-2/24,GKFMSLLKHILK,50.0,34.0000,μM,12,4.4685
N29D,PDEDAINDALNKVCSTGRRQRSICKQLLKK,60.0,<50.0000,μM,30,4.466
FLAK 50P,FAKLLAKALKKL,50.0,34.2300,μM,12,4.4656
KL2,KLLKLLKLKKLLKL,50.0,34.5000,μM,14,4.4622
HAL-1/17,KMWSKILGHLIR,50.0,35.0000,μM,12,4.4559
Phylloseptin-L1,LLGMIPLAISAISALSKL,50.0,35.0000,μM,18,4.4559
"PMAP-23, Myeloid antibacterial peptide 23",RIIDLLWRVRRPQKPKFVTVWVR,50.0,35.0000,μM,23,4.4559
Alyteserin-2a [S7K],ILGKLLKTAAGLLSNL,50.0,35.0000,μM,16,4.4559
BPC198,KLKKKFKKLQ,50.0,35.0000,μM,10,4.4559
ND4,GLFDIVKKLKSLF,50.0,35.2600,μM,13,4.4527
Tritrp-W68Y,VRRFPYWYPFLRR,50.0,35.4000,μM,13,4.451
BPC202,KKKKKFKKLQ,50.0,35.5000,μM,10,4.4498
IL-4,FKIGGFIKKLWRSALA,50.0,35.5000,μM,16,4.4498
P18,KWKLFKKIPKFLHLAKKF,52.5,40.0000,μM,18,4.4488
BP307,RRLFRRILRYL,50.0,35.7000,μM,11,4.4473
Modelin-5,KLAKKLAKLAKLAKAL,50.0,35.7100,μM,16,4.4472
PenArg,RQIRIWFQNRRMRWRR,50.0,36.0000,μM,16,4.4437
N1,KRKRKILILIKRK,50.0,36.0000,μM,13,4.4437
Pen13Arg,RIWFQNRRMRWRR,50.0,36.0000,μM,13,4.4437
Cyclopeptide GG-8-6 [I4A],VLPALLLVL,50.0,36.0800,μM,9,4.4427
P2,KWKLFKKIGIGKFLHSATTF,50.0,36.2000,μM,20,4.4413
12,GLFKIISKLAKKA,50.0,36.3000,μM,13,4.4401
"Phylloseptin-Pha [A7K, V12I]",FLSLIPKAISAISALANHF,50.0,36.4600,μM,19,4.4382
Tritrp-W6A,VRRFPAWWPFLRR,50.0,36.5000,μM,13,4.4377
B1-Glu,VKRFKKFFRKLKKEV,50.0,36.6000,μM,15,4.4365
C7A,KILRGVAKKIMRTFLRRISKDILTGKK,50.0,37.0000,μM,27,4.4318
Pep27anal1,MWKWFHNVLSSWQLLADKRPARDYNRK,50.0,37.0000,μM,27,4.4318
ALK-2,CLKKLLKLLKKLLKLCLEHLLEHLEHLLEH,40.0,20.0000,μM,30,4.4297
ALK-1,CLHELLEHLHELLEHCLKKLLKLLKKLLKL,40.0,20.0000,μM,30,4.4297
PNC-28,ETFSDLWKLL,100.0,75.0000,μM,10,4.4231
Pep27anal3,MRKWFHNVLSSGQLLADKWPAWDYNRK,50.0,38.0000,μM,27,4.4202
Decoralin [AC9],QLLQLIRKLIR,50.0,38.0000,μM,11,4.4202
LL-37(13-37),IGKEFKRIVQRIKDFLRNLVPRTES,50.0,38.0000,μM,25,4.4202
HAL-2/4,GKWMSLLKKILK,50.0,38.0000,μM,12,4.4202
Unknown,FPYG,50.0,38.2000,μM,4,4.4179
BPC98,LLKKKFKKLQ,50.0,38.5000,μM,10,4.4145
Cyclopeptide GG-8-6 [L9A],VLPILLLVA,50.0,38.6400,μM,9,4.413
Chaxapeptin,GFGSKPLDSFGLNFF,56.0,50.0000,μM,15,4.4121
L187V,GCRVYGFKIHGCG,50.0,38.9000,μM,13,4.4101
Decoralin [AC10],QLLQLIRKLIK,50.0,39.0000,μM,11,4.4089
AmphiArc2 Off7,RLIKRLKTFVRKTWKWVGHF,50.0,39.0000,μM,20,4.4089
Decoralin [AT5],QLLLLIRKLIL,50.0,39.0000,μM,11,4.4089
Buforin 2,TRSSRAGLQFPVGRVHRLLRK,50.0,~39.0200,μM,21,4.4087
Cyclopeptide GG-8-6 [L2A],VAPILLLVL,50.0,39.3700,μM,9,4.4048
RFR-ChBac3.4 (1-14)-NH2,RFRRFRLPFRRPPIRIH,50.0,39.4000,μM,17,4.4045
HYL-2,GAMSSLMKKLAAHIAK,50.0,39.5700,μM,16,4.4026
"sC18 [R10F,K16F]",GLRKRLRKFFNKIKEF,50.0,<40.0000,μM,16,4.3979
Jindongenin-1a,DSMGAVKLAKLLIDKMKCEVTKAC,50.0,40.0000,μM,24,4.3979
NK-2,KILRGVCKKIMRTFLRRISKDILTGKK,50.0,~40.0000,μM,27,4.3979
PL-D 41,VRLRIRVRVIRK,50.0,40.2000,μM,12,4.3958
Cyclopeptide GG-8-6 [V8A],VLPILLLAL,50.0,40.4600,μM,9,4.393
Amurin-2a [L4K],FLPKLLAGLPSFLCLVFKKC,50.0,41.6000,μM,20,4.3809
ND3,GLFDIVKKIKSLF,50.0,41.7800,μM,13,4.379
SFTI-polyR-L2,CTKSIPPICRRKRRR,50.0,41.8400,μM,15,4.3784
FLAK99,KLALKLALKALKAAKLA,50.0,41.9400,μM,17,4.3774
"Apidaecin-1B [R4K, I8R]",GNNKPVYRPQPRPPHPRL,30.0,10.0000,μM,18,4.3773
V3,CVKVRVKVGSGVKVRVKVC,50.0,42.0000,μM,19,4.3768
Unknown,RWNGRIIKGFYNLVKIWKDLKG,50.0,42.0000,μM,22,4.3768
FLAK50C,FAKLLAKLAKKAL,50.0,42.4100,μM,13,4.3725
Cyclopeptide GG-8-6 [L6A],VLPILALVL,50.0,42.8100,μM,9,4.3685
B18KA,GFQKAKAKALACLAKALA,50.0,43.5000,μM,18,4.3615
IL-2,FKIGGFAKKLWRSLLA,50.0,43.6000,μM,16,4.3605
PST13-RK,KKKFPWWWPFKKK,50.0,43.6100,μM,13,4.3604
Kalata B1 [T16S],GLPVCGETCVGGTCNSPGCTCSWPVCTRN,50.0,43.8000,μM,29,4.3585
Dermaseptin S4 (5-28),TLLKKVLKAAAKAALNAVLVGANA,50.0,43.9000,μM,24,4.3575
ovispirin-1,KNLRRIIRKIIHIIKKYG,100.0,88.3800,μM,18,4.3518
FKRLA,FKRLAKIKVLRLAKIKR,50.0,44.6800,μM,17,4.3499
Temporin-1CEa LK2(5),FKDLKKIANIINSIFKK,50.0,44.7000,μM,17,4.3497
V1,CVKVKVKVGSGVKVKVKVC,50.0,45.0000,μM,19,4.3468
V6,CFKFKFKFGSGFKFKFKFC,50.0,45.0000,μM,19,4.3468
From_Paper_114,ERRVGYSWYGTWGNKVLKKYPEWLRRLTEKK,40.42254,25.0000,μM,31,4.3461
Unknown,AFLYRLTRQIRPWWRWLYKW,50.0,45.5000,μM,20,4.342
GW-M1,GANAAKKLATFAKKIFTAYW,50.0,46.0000,μM,20,4.3372
FLAK120,FALALKALKKL,50.0,46.0700,μM,11,4.3366
NRC-06,GWGSIFKHGRHAAKHIGHAAVNHYL,50.0,46.2900,μM,25,4.3345
novispirin T-7,KNLRRITRKIIHIIKKYG,81.5,88.8600,μM,18,4.3341
FLAK 06R-AM,FAKKLAKKLKKLAKLALAK,50.0,46.4100,μM,19,4.3334
FLAK50 Q6,FAKLLAKALKKFL,50.0,46.9500,μM,13,4.3284
NRC-124,GIRKWFKKAAHVGKEVGKVALNACL,50.0,46.9800,μM,25,4.3281
Unknown,KLWKKIEKLIKKLLTSIR,50.0,47.0000,μM,18,4.3279
Unknown,DLFKQLQRLFLGILYCLYKIW,50.0,47.0000,μM,21,4.3279
PL-D 5,WRKFWKYLK,50.0,47.3000,μM,9,4.3251
Omiganan MBI-226,ILRWPWWPWRRK,50.0,~47.7500,μM,12,4.321
PL-D 12,RLKRWWKFL,50.0,48.0000,μM,9,4.3188
"Temporin-1Sa [S3K], SEQ ID NO:29 for Patent EP 2853538 A1",FLKGIVGMLGKLE,50.0,48.0000,μM,13,4.3188
Tritrp-W7A,VRRFPWAWPFLRR,50.0,48.2000,μM,13,4.317
NRC-05,FLGALIKGAIHGGRFIHGMIQNHH,50.0,48.7600,μM,24,4.3119
PL-D 18,KFKWWRMLI,50.0,49.0000,μM,9,4.3098
[Arg]1 -Dec-NH2,RLLSLIRKLIT,50.0,50.0000,μM,11,4.301
AmphiArc4,RIENGLRKRLQSIYRHLEE,50.0,>50.0000,μM,19,4.301
Temporin-1Oc,FLPLLASLFSRLF,50.0,50.0000,μM,13,4.301
Gradient3,KVVDNFENILII,50.0,>50.0000,μM,12,4.301
Unknown,RIWGKHSRYIKIVKRLIQ,50.0,50.0000,μM,18,4.301
Bac2a [L2R][A3W][A11R],RRWRIVVIRVRR,50.0,>50.0000,μM,12,4.301
Modifed Opero2,GLKKVIKLLRPLL,50.0,50.0000,μM,13,4.301
Helical3,GLLDIAGGNAETLAGHAV,50.0,>50.0000,μM,18,4.301
CRAMP (20-35),KKIGQKIKNFFQKL,50.0,>50.0000,μM,14,4.301
CRAMP (20-35)[G4W],KKIWQKIKNFFQKL,50.0,>50.0000,μM,14,4.301
[Leu]8 -Dec-NH2,SLLSLIRLLIT,50.0,>50.0000,μM,11,4.301
[Phe]2 -Dec-NH2,SFLSLIRKLIT,50.0,50.0000,μM,11,4.301
CRAMP (20-35)[G4W][K8R],KKIWQKIRNFFQKL,50.0,>50.0000,μM,14,4.301
CRAMP (20-35)[G4W][K6R],KKIWQRIKNFFQKL,50.0,50.0000,μM,14,4.301
CRAMP (20-35)[G4W][K8R],KKIWQKIKRFFQKL,50.0,>50.0000,μM,14,4.301
CRAMP (20-35)[G4W][Q12R],KKIWQKIKNFFRKL,50.0,>50.0000,μM,14,4.301
Trichoplaxin,FFGRLKSVWSAVKHGWKAAKSR,50.0,~50.0000,μM,22,4.301
Helical4,GLFDVIGSQAGGAAPHFLG,50.0,>50.0000,μM,19,4.301
CRAMP (20-35)[K2R][G4W],KRIWQKIKNFFQKL,50.0,>50.0000,μM,14,4.301
HYL-12,GIMSSLMKKLAAHAAK,50.0,>50.0000,μM,16,4.301
KT2,NGVQPKYKWWKWWKKWW,50.0,50.0000,μM,17,4.301
[Phe]6 -Dec-NH2,SLLSLFRKLIT,50.0,>50.0000,μM,11,4.301
HYL-10,GIMSSLMKKAAAHIAK,50.0,>50.0000,μM,16,4.301
HYL-6,GIMSSAMKKLAAHIAK,50.0,>50.0000,μM,16,4.301
Gradient4,RVNAAIPNIIV,50.0,>50.0000,μM,11,4.301
Helical2,GLWAIAVKAGKVILKLIVFIWIRV,50.0,>50.0000,μM,24,4.301
[Phe]6 -Dec[Thr]11-Dec-NH2,SLLSLFRKLI,50.0,50.0000,μM,10,4.301
AmphiArc3,AFRHSVKEELNYIRRRLERFPNRL,50.0,>50.0000,μM,24,4.301
Cyclonellin,ANPRYPYT,50.0,>50.0000,μM,8,4.301
Gradient1,KWVRIWIKVLRGLFVWVWFF,50.0,>50.0000,μM,20,4.301
ND2,GLFDIVKGIKSLF,50.0,50.1100,μM,13,4.3001
DM4,GLFDIWKKWRWRR,50.0,50.5100,μM,13,4.2966
SOR-C27,EGKLSSNDTEGGLCKEFLHPSKVDLPR,95.0,~100.0000,μM,27,4.2962
PCC-1,KKRKKKAFALKFVVDLI,50.0,50.8000,μM,17,4.2941
"Temporin-1Sa [S3K,V6K,F13L], SEQ ID NO:8 for Patent EP 2853538 A1",FLKGIKGMLGKLL,50.0,51.0000,μM,13,4.2924
NRC-01,GKGRWLERIGKAGGIIIGGALDHL,50.0,51.4500,μM,24,4.2886
AMP 24,LRRLRRLLRRL,85.0,100.0000,μM,11,4.2881
Cyclopeptide GG-8-6 (1-8),VLPILLLV,50.0,51.7200,μM,8,4.2863
FLAK50 T3,FAKLLAKLAKKIL,50.0,52.1700,μM,13,4.2826
Tat-a5,KAQIRAMECNILGRKKRRQRRR,80.0,~100.0000,μM,22,4.2799
AMP 22,LRKVWRWLRRL,80.0,100.0000,μM,11,4.2799
Latarcin-1,SMWSGMWRRKLKKLRNALKKKLKGE,50.0,52.5100,μM,25,4.2798
TsAP-1 (T. serrulatus antimicrobial peptide 1),FLSLIPSLVGGSISAFK,50.0,52.5000,μM,17,4.2798
B1CTcu5-LIAG,LAANFLPQILCKIARKC,50.0,>52.5700,μM,17,4.2793
Gymnin,KTCENLADDY,49.0,50.0000,μM,10,4.2788
CMAP-L-242,KKFFKKMKKFVKKFL,79.0,~100.0000,μM,15,4.2778
Decoralin [AT6],QLLLLIRKLIV,50.0,53.0000,μM,11,4.2757
BP100 [Y10Q],KKLFKKILKQL,50.0,53.3000,μM,11,4.2733
FLAK43 AM V,VAKKLAKLAKKLLAL,50.0,53.4800,μM,15,4.2718
AMP2,KRWWKWWRR,50.0,53.5000,μM,9,4.2716
Dermaseptin S4 (1-28),ALWMTLLKKVLKAAAKAALNAVLVGANA,66.5,89.8100,μM,28,4.2714
Brevinin-1 CEa,FLIGMTQGLICLITRKC,50.0,54.0000,μM,17,4.2676
CMAP-L-25,KKFFKKMKKFVKKFF,75.0,~100.0000,μM,15,4.2668
DM5,GLFDIWKKLRWRR,50.0,54.6700,μM,13,4.2623
"Temporin-1Sa [S3K,V6K], SEQ ID NO:3 for Patent EP 2853538 A1",FLKGIKGMLGKLF,50.0,55.0000,μM,13,4.2596
"Bac5 (1-17)[F2,15W; P4W; P9,17R]",RWRWPIRRRPIRPPWYR,41.0,32.0000,μM,17,4.2569
Temporin-CEb,ILPILSLIGGLL,50.0,56.0000,μM,12,4.2518
Unknown,YIWARAERVWLWWGKFLSL,50.0,56.0000,μM,19,4.2518
AmphiArc2 Off10,HRIRQLKTTIKKFWEIWPKI,50.0,56.0000,μM,20,4.2518
Citropin-a,GLFAVIHKVASVIGGL,50.0,56.0000,μM,16,4.2518
Dermaseptin S4 (1-24)a,ALWMTLLKKVLKAAAKAALNAVLV,71.48,100.9000,μM,24,4.2492
PL-D 3,ILPWKWRWWKWRR,50.0,56.4000,μM,13,4.2487
NRC-18,GWKKWFTKGERLSQRHFA,50.0,>56.5700,μM,18,4.2474
NRC-10,FFRLLFHGVHHVGKIKPRA,50.0,>56.6400,μM,19,4.2469
Palustrin-2AJ1,GFMDTAKNVAKNVAVTLIDKLRCKVTGGC,50.0,57.0000,μM,29,4.2441
BP100 [Y10R],KKLFKKILKRL,50.0,57.3000,μM,11,4.2418
Demegen P-113,AKRHHGYKRKFH,50.0,57.5200,μM,12,4.2402
coloy(Trp-Ala-Val-Ile-Leu),WAVIL,50.0,57.8300,μM,5,4.2378
N4,KILILIKRK,50.0,58.0000,μM,9,4.2366
IsCT,ILGKIWKGIKSLF,50.0,58.0000,μM,13,4.2366
S-24-R2Plx,GIMDTVKNAAKNLAGQLLDKLKCSITAC,50.0,58.1800,μM,28,4.2352
IL-1,FKAGGFIKKLWRSLLA,50.0,58.4000,μM,16,4.2336
NRC-08,RSTEDIIKSISGGGFLNAMNA,50.0,>58.6800,μM,21,4.2315
Sungsanpin,GFGSKPIDSFGLSWL,47.0,50.0000,μM,15,4.231
NRC-02,WLRRIGKGVKIIGGAALDHL,50.0,>58.8900,μM,20,4.23
"Temporin-1Tb [L1F,N7L,L9del]-K",FLPIVGLLKSLLK,50.0,59.0000,μM,13,4.2291
LL-1c,FLGALWHALSHLL,50.0,59.0000,μM,13,4.2291
PL-D 19,FIKWKFRWWKWRK,50.0,59.1000,μM,13,4.2284
Magainin 2,GIGKFLHSAKKFGKAFVGEIMNS,50.0,59.4000,μM,23,4.2262
Modelin-8E,KFKKLAKKW,50.0,59.5000,μM,9,4.2255
RN3(5-17P22-36)[Q12I],RPFTRAQWFAIIHISPRTIAMRAINNYRWR,50.0,59.6400,μM,30,4.2245
"Temporin-1Sa, SEQ ID NO:1 for Patent EP 2853538 A1",FLSGIVGMLGKLE,50.0,>60.0000,μM,13,4.2218
"Temporin-1Sa [S3K,M8K], SEQ ID NO:4 for Patent EP 2853538 A1",FLKGIVGKLGKLF,50.0,60.0000,μM,13,4.2218
EH-APP(40-64),GFIATLCTKVLDFGIDKLIQLIEDK,50.0,60.0000,μM,25,4.2218
"Temporin-1Sa [L2,9A;V6A]",FASGIAGMAGKLF,50.0,>60.0000,μM,13,4.2218
TetraF2W-RR,WWWLRRIW,50.0,60.0000,μM,8,4.2218
FLAK98,KYKKALKKLAKLL,50.0,60.1900,μM,13,4.2205
NRC-09,FFRLLFHGVHHGGGYLNAA,50.0,>60.5700,μM,19,4.2177
C1,KRKILILIKRKRK,50.0,61.0000,μM,13,4.2147
CMAP-L-24,KKFFKKMKKLVKKFF,65.0,~100.0000,μM,15,4.2136
Temporin-ALa,FLPIVGKLLSGLSGLL,50.0,>61.4600,μM,16,4.2114
MAP-04-03,KWLRRVWRWWR,50.0,61.5000,μM,11,4.2111
FLAK 50G,FAKLLAKLAKLKL,50.0,61.7800,μM,13,4.2092
C-3,KWKLFKKIPLHLAKKF,50.0,62.0000,μM,16,4.2076
FLAK50 Q1V,VAKFLAKFLKKAL,50.0,62.2900,μM,13,4.2056
N2,RKRKILILIKRK,50.0,>64.0000,μM,12,4.1938
N8,LIKRK,50.0,>64.0000,μM,5,4.1938
M3,ILILILILKRK,50.0,>64.0000,μM,11,4.1938
A5,LILKRKRKRKRILI,50.0,>64.0000,μM,14,4.1938
C4,KRKILILIK,50.0,>64.0000,μM,9,4.1938
C3,KRKILILIKR,50.0,>64.0000,μM,10,4.1938
A4,KLILKRKRKRILIK,50.0,>64.0000,μM,14,4.1938
M5,GSGILILIKRK,50.0,>64.0000,μM,11,4.1938
H2,KRKLILIKRK,50.0,>64.0000,μM,10,4.1938
A2,KRKLILKRILIKRK,50.0,>64.0000,μM,14,4.1938
N6,LILIKRK,50.0,>64.0000,μM,7,4.1938
N3,RKILILIKRK,50.0,>64.0000,μM,10,4.1938
S3,RRRLLLLLRRR,50.0,>64.0000,μM,11,4.1938
"Leucocin A (18-35)[G2,8,15,16L;E3R;S6R;A7R;H10R;N14,17R;G18R]",WLRAFRRLVRRLARLLRR,50.0,>64.0000,μM,18,4.1938
"Leucocin A (18-35)[E3R;S6R;A7R;H10R;N14,17R;G18R]",WGRAFRRGVRRLARGGRR,50.0,>64.0000,μM,18,4.1938
S4,KKKLLLLLKKK,50.0,>64.0000,μM,11,4.1938
S6,KKKVVVVVKKK,50.0,>64.0000,μM,11,4.1938
M4,KRKILILIGSG,50.0,>64.0000,μM,11,4.1938
C5,KRKILILI,50.0,>64.0000,μM,8,4.1938
C6,KRKILIL,50.0,>64.0000,μM,7,4.1938
C8,KRKIL,50.0,>64.0000,μM,5,4.1938
C7,KRKILI,50.0,>64.0000,μM,6,4.1938
H8,KRKGSGKRK,50.0,>64.0000,μM,9,4.1938
O1,KKKIIIIIIKKK,50.0,>64.0000,μM,12,4.1938
S2,KKKIIIIIKKK,50.0,>64.0000,μM,11,4.1938
S8,KKKFFFFFKKK,50.0,>64.0000,μM,11,4.1938
S5,RRRVVVVVRRR,50.0,>64.0000,μM,11,4.1938
S7,RRRFFFFFRRR,50.0,>64.0000,μM,11,4.1938
M6,KRKSGSGSKRK,50.0,>64.0000,μM,11,4.1938
H3,KRKILIKRK,50.0,>64.0000,μM,9,4.1938
H5,KRKIKRK,50.0,>64.0000,μM,7,4.1938
Leucocin A (18-35)[E3R],WGRAFSAGVHRLANGGNG,50.0,>64.0000,μM,18,4.1938
H1,KRKILILILIKRK,50.0,>64.0000,μM,13,4.1938
N5,ILILIKRK,50.0,>64.0000,μM,8,4.1938
N7,ILIKRK,50.0,>64.0000,μM,6,4.1938
H7,KRKGKRK,50.0,>64.0000,μM,7,4.1938
M2,KRKILILILIL,50.0,>64.0000,μM,11,4.1938
H6,KRKKRK,50.0,>64.0000,μM,6,4.1938
H4,KRKLIKRK,50.0,>64.0000,μM,8,4.1938
S1,RRRIIIIIRRR,50.0,>64.0000,μM,11,4.1938
"Leucocin A (18-35)[E3R;N14,17R]",WGRAFSAGVHRLARGGRG,50.0,64.0000,μM,18,4.1938
"Leucocin A (18-35)[E3R;A7R;H10R;N14,17R]",WGRAFSRGVRRLARGGRG,50.0,64.0000,μM,18,4.1938
Leucocin A (18-35),WGEAFSAGVHRLANGGNG,50.0,>64.0000,μM,18,4.1938
A1,RKRKLILILIKRKR,50.0,>64.0000,μM,14,4.1938
A3,RKLILKRKRILIKR,50.0,>64.0000,μM,14,4.1938
M1,KRKILILIKRK,50.0,>64.0000,μM,11,4.1938
C2,KRKILILIKRKR,50.0,>64.0000,μM,12,4.1938
GN-6,RKRWWWWFR,50.0,64.3800,μM,9,4.1912
Temporin A,FLPLIGRVLSGIL,50.0,64.3900,μM,13,4.1912
YR,YGFVMPRSGLWFR,50.0,64.3900,μM,13,4.1912
FLAK100-CO2H,KLLKLLLKLYKKLLKLL,50.0,64.8500,μM,17,4.1881
Frenatin 2.2S,GLVGTLLGHIGKAILS,50.0,65.0000,μM,16,4.1871
CA-MA1,KWKLFKKIKFLHSAKKF,50.0,65.0000,μM,17,4.1871
Combi-1,RRWWRF,50.0,≥65.0000,μM,6,4.1871
AmphiArc2 Off2.3,TLYKKFRHFLKKPWHVVGKI,50.0,65.0000,μM,20,4.1871
LysH,RAWVAWR,50.0,65.0000,μM,7,4.1871
PuroB3,FRVTWRTKWWKG,50.0,≥65.0000,μM,12,4.1871
Combi-2,FRWWHR,50.0,≥65.0000,μM,6,4.1871
Alyteserin-2a,ILGKLLSTAAGLLSNL,50.0,65.0000,μM,16,4.1871
[Lys11] XT-7,GLLGPLLKIAKKVGSNLL,50.0,65.0000,μM,18,4.1871
Tritrp-W678A,VRRFPAAAPFLRR,50.0,≥65.0000,μM,13,4.1871
Tritrp-W67A,VRRFPAAWPFLRR,50.0,≥65.0000,μM,13,4.1871
Tritrp-W68A,VRRFPAWAPFLRR,50.0,≥65.0000,μM,13,4.1871
Tritrp-W78A,VRRFPWAAPFLRR,50.0,≥65.0000,μM,13,4.1871
Tritrp-W678Y,VRRFPYYYPFLRR,50.0,≥65.0000,μM,13,4.1871
FLAK 25 AM V,VAKKLAKLAKKLAKLALAL,50.0,65.2700,μM,19,4.1853
"LL37 (14-21)+Indolicidin (5-13), LI",GKEFKRIVKWPWWPWRR,87.5,128.0000,μM,17,4.1837
C7S/NK27,KILRGVSKKIMRTFLRRISKDILTGKK,38.4,31.3800,μM,27,4.1822
Dermaseptin S4 (1-22)a,ALWMTLLKKVLKAAAKAALNAV,66.21,110.1100,μM,22,4.1809
CRAMP-18[Q9K],GEKLKKIGKKIKNFFQKL,50.0,66.0000,μM,18,4.1805
FLAK06 R-AC,FAKKLAKKLKKLAKLALAL,50.0,66.7700,μM,19,4.1754
Temporin-1Tb,LLPIVGNLLKSLL,50.0,66.7700,μM,13,4.1754
C-5,KWKLFKKIPHLAKKF,50.0,67.0000,μM,15,4.1739
ND1,GLFDIWKGIKSLF,50.0,67.1500,μM,13,4.173
"LL37 (14-21)+NP-1 (23-31), LN",GKEFKRIVGRIYRLCCR,80.0,128.0000,μM,17,4.1727
CLP,LP,50.0,67.4000,μM,2,4.1713
Z4,KAAKKAWKAAKKAAKWWKKAA,50.0,68.0000,μM,21,4.1675
AmphiArc2 Off2.2.4,QVLKKVRTWYRKAFHVIGKV,50.0,68.0000,μM,20,4.1675
MG2d,GIGKFLHSAKKWGKAFVGQIMNC,60.0,~100.0000,μM,23,4.165
GN-3,KWWRWRRWW,50.0,68.5700,μM,9,4.1639
From_Paper_111,LLSDFRQYRTKIVRQMRRQIFRQMKQKAE,34.98467,25.0000,μM,29,4.1636
Pep27anal5,MWKWFHNVLSSGQLLADKWWAWWYNWW,50.0,>70.0000,μM,27,4.1549
Pep27,MRKEFHNVLSSGQLLADKRPARDYNRK,50.0,>70.0000,μM,27,4.1549
TetraF2W-KK,WWWLKKIW,50.0,70.0000,μM,8,4.1549
FLAG26-D3,FAKKLLAKALKL,50.0,70.7000,μM,12,4.1506
BP100 [Y10D],KKLFKKILKDL,50.0,70.7000,μM,11,4.1506
YALPAG,YALPAG,50.0,71.2000,μM,6,4.1475
KFK(9),KFKKFKKFKKFKKFKKFKKFKKFKKFK,80.7,137.0000,μM,27,4.1446
I192W,GCRLYGFKWHGCG,50.0,72.9000,μM,13,4.1373
Diketopiperazine (GC),GC,57.79,100.0000,μM,2,4.137
PL-D 4,RWRRKWWWW,50.0,73.0000,μM,9,4.1367
Temporin-G,FFPVIGRILNGIL,50.0,73.0000,μM,13,4.1367
B7,KKLFKKILKY,50.0,73.7000,μM,10,4.1325
FLAK 72,FAKKLAKKAKLAKKL,50.0,74.1300,μM,15,4.13
"RNase 3 (1-36)[P3,Q4,L18,N19,P20,C23DEL], RN3(5-17P22-36)",RPFTRAQWFAIQHISPRTIAMRAINNYRWR,50.0,74.4300,μM,30,4.1283
BP327,CREKAKKLFKKILKKL,50.0,74.7000,μM,16,4.1267
IL-3,FKIGGFIKKAWRSLLA,50.0,74.9000,μM,16,4.1255
CA-MA3,KWKLFKKIGPGKFLHSAKKF,50.0,75.0000,μM,20,4.1249
L11,PAARKAARWAWRMLKKGA,50.0,75.0000,μM,18,4.1249
Decoralin [AT7],CLLLLIRKLIL,50.0,76.0000,μM,11,4.1192
AmphiArc2 Off2.2.1,QVVKKIRTWYHKAWHVLGKV,50.0,76.0000,μM,20,4.1192
KFAF(7),KFAFKFAFKFAFKFAFKFAFKFAFKFAF,76.8,143.9600,μM,28,4.114
Pep1,FKCRRWQWRMKKLGAPSITCVR,50.0,77.0000,μM,22,4.1135
D2A21V,VAKKFAKKFKKFAKKFAKFAFAF,50.0,77.0000,μM,23,4.1135
CRAMP-18[N13K],GEKLKKIGQKIKKFFQKL,50.0,78.0000,μM,18,4.1079
BP100 [Y10E],KKLFKKILKEL,50.0,79.5000,μM,11,4.0996
KFK(8),KFKKFKKFKKFKKFKKFKKFKKFK,84.2,154.0300,μM,24,4.0994
KKAK(7),KKAKKKAKKKAKKKAKKKAKKKAKKKAK,87.9,<155.9000,μM,28,4.0985
Temporin-CPb,FLPIVGRLISGIL,50.0,>80.0000,μM,13,4.0969
L5c,PAWRHAFHWAWHMLHKAA,50.0,>80.0000,μM,18,4.0969
Temporin-CPa,IPPFIKKVLTTVF,50.0,80.0000,μM,13,4.0969
Frenatin 2.1S,GLVGTLLGHIGKAILG,50.0,80.0000,μM,16,4.0969
Temporin-1SPa,FLSAITSILGKFF,50.0,>80.0000,μM,13,4.0969
Temporin-1Ga,SILPTIVSFLSKVF,50.0,>80.0000,μM,14,4.0969
Dermaseptin S4 (3-28)a,WMTLLKKVLKAAAKAALNAVLVGANA,54.02,96.0100,μM,26,4.0963
SEQ ID NO.1 of Patent CN114409737A,KLLKFIWRI,55.0,100.0000,μM,9,4.0951
FLAK44 AM,FAKKLAKLAKKALAL,50.0,80.5400,μM,15,4.094
HS3,CGAISLAKLQINES,50.0,80.7000,μM,14,4.0931
FAGVL,FAVGLRAIKRALKKLRRGVRKVAKDL,50.0,80.9800,μM,26,4.0916
BmKn-22,FIGAIARLLSK,50.0,81.6200,μM,11,4.0882
coloy(Trp-Thr-Val-Leu-Leu),WTVLL,50.0,81.6400,μM,5,4.0881
polyR,RRKRRR,50.0,83.5100,μM,6,4.0783
L6A/L17A,KWKSFAKTFKSAKKTVAHTALKAISS,50.0,>83.6000,μM,26,4.0778
ALK-3,CLKKLLKLLKKLLKLCLEELLHHLEELLHH,30.0,20.0000,μM,30,4.0763
CP-EPS8-NLS,GRKKRRQRRRPQSKRKKNKKGKRK,55.0,~105.0000,μM,24,4.074
PL-D 15,KRWWRKWWR,50.0,84.4000,μM,9,4.0737
V7,CWKWKWKWGSGWKWKWKWC,50.0,85.0000,μM,19,4.0706
LL-37 (17-29) [R23K],FKRIVQKIKDFLR,50.0,85.8000,μM,13,4.0665
P-52,WEQKIEELLKKAEEQQKKNEEELKKLEK,50.0,85.8300,μM,28,4.0664
GN-5,KKRWWWWWR,50.0,86.3100,μM,9,4.0639
FLAK71,FAKKLKKLAKLAKKL,50.0,86.7900,μM,15,4.0615
L8,PAWAKAFRAAARMKLKAA,50.0,87.0000,μM,18,4.0605
PL-D 9,RLWWWWRRK,50.0,87.0000,μM,9,4.0605
L15,PAWRKARRWARRMKKLAA,50.0,87.0000,μM,18,4.0605
V4,CVKVQVKVGSGVKVQVKVC,50.0,88.0000,μM,19,4.0555
Flak 96I,FALLKALLKKAL,50.0,90.3100,μM,12,4.0443
PL-D 10,KWKWWWRKI,50.0,90.4000,μM,9,4.0438
KAAK(7),KAAKKAAKKAAKKAAKKAAKKAAKKAAK,90.0,178.0900,μM,28,4.0425
AmphiArc2 Off2.1,QVFKKFRPFYRRPWELFGKL,50.0,91.0000,μM,20,4.041
KFK(7),KFKKFKKFKKFKKFKKFKKFK,80.9,175.8900,μM,21,4.0365
HHPHG,HHPHG,50.0,92.0000,μM,5,4.0362
V681 [V13E],KWKSFLKTFKSAEKTVLHTALKAISS,50.0,92.0400,μM,26,4.036
Shiva 10(1-18 AC),FAKKLAKKLKKLAKKLAK,50.0,92.4300,μM,18,4.0342
KFK(10),KFKKFKKFKKFKKFKKFKKFKKFKKFKKFK,56.8,123.3600,μM,30,4.0319
Bim SM-5,IAQELRRIGDEF,40.0,50.0000,μM,12,4.0317
Cecropin P1,SWLSKTAKKLENSAKKRISEGIAIAIQGGPR,50.0,93.0000,μM,31,4.0315
KKFA(6),KKFAKKFAKKFAKKFAKKFAKKFA,76.4,174.4800,μM,24,4.0293
HS2,CGAISLAPKLQIKES,50.0,93.5000,μM,15,4.0292
PL-D 32,RRRWWKLMM,50.0,94.0000,μM,9,4.0269
Unknown,AIKKFGPLAKIVAKV,50.0,95.0000,μM,15,4.0223
PTPRJ-pep19.4,CHHALTHAC,66.5,160.0000,μM,9,4.0206
Retro Mastoparan,LIKKALAALAKLNI,50.0,95.4600,μM,14,4.0202
RN3(5-17P22-36)[T4I],RPFIRAQWFAIQHISPRTIAMRAINNYRWR,50.0,95.7800,μM,30,4.0187
Citropin-b,GLFAVIKHVASVIGGL,50.0,97.0000,μM,16,4.0132
BP308,RRLFRRILRRL,50.0,97.0000,μM,11,4.0132
coloy(Trp-Ala-Val-Leu-Leu),WAVLL,50.0,97.2700,μM,5,4.012
LR(11),LRLRLRLRLRLRLRLRLRLRLR,66.6,167.7400,μM,22,4.0008
From_Paper_45,YQAENKH,50.0,>100.0000,μM,7,4.0
From_Paper_46,EQGEQN,50.0,>100.0000,μM,6,4.0
From_Paper_47,FPEQQD,50.0,>100.0000,μM,6,4.0
From_Paper_44,YKYHES,50.0,>100.0000,μM,6,4.0
From_Paper_48,EFPEQN,50.0,>100.0000,μM,6,4.0
From_Paper_43,YGRGV,50.0,>100.0000,μM,5,4.0
From_Paper_49,FEGDQDA,50.0,>100.0000,μM,7,4.0
From_Paper_50,LGDDLVK,50.0,>100.0000,μM,7,4.0
From_Paper_35,KADGNR,50.0,>100.0000,μM,6,4.0
From_Paper_36,KGYEAV,50.0,>100.0000,μM,6,4.0
From_Paper_38,NGDDEEG,50.0,>100.0000,μM,7,4.0
From_Paper_58,EPDDPDD,50.0,>100.0000,μM,7,4.0
From_Paper_25,ESCAPQL,50.0,>100.0000,μM,7,4.0
From_Paper_12,AGCD,50.0,>100.0000,μM,4,4.0
From_Paper_13,KCGQ,50.0,>100.0000,μM,4,4.0
From_Paper_14,RPLGNC,50.0,>100.0000,μM,6,4.0
From_Paper_15,CALTP,50.0,>100.0000,μM,5,4.0
Esculentin-2CHa (7–37),RGVAKFASKGLGKDLAKLGVDLVACKISKQC,50.0,>100.0000,μM,31,4.0
Cyclopeptide GG-8-6 (1-7),VLPILLL,50.0,>100.0000,μM,7,4.0
Astacidin PcAst-2,FYPRPYRPPYLPDPRPFPRPLPAFGHEFRRH,50.0,>100.0000,μM,31,4.0
Cyclopeptide GG-8-6 (1-5),VLPIL,50.0,>100.0000,μM,5,4.0
From_Paper_37,LQPDAGK,50.0,>100.0000,μM,7,4.0
20,GDGDIMKGIAGH,50.0,>100.0000,μM,12,4.0
CRAMP-18[Q16K],GEKLKKIGQKIKNFFKKL,50.0,>100.0000,μM,18,4.0
CRAMP-18,GEKLKKIGQKIKNFFQKL,50.0,>100.0000,μM,18,4.0
7,GIVTILKGAVGVILGGL,50.0,>100.0000,μM,17,4.0
HAL-1/19,GKWKKILGHLIR,50.0,>100.0000,μM,12,4.0
Astacidin PcAst-1a,SNGYRPAYRPAYRPSYRP,50.0,>100.0000,μM,18,4.0
Astacidin PcAst-1b/c,SNVYRPPPYRPVYRPLRRPGYRP,50.0,>100.0000,μM,23,4.0
From_Paper_55,LQDVVE,50.0,>100.0000,μM,6,4.0
From_Paper_56,TQEVVN,50.0,>100.0000,μM,6,4.0
From_Paper_57,TIDDELR,50.0,>100.0000,μM,7,4.0
Cyclopeptide GG-8-6 (1-6),VLPILL,50.0,>100.0000,μM,6,4.0
21,GLPQIISKVVKT,50.0,>100.0000,μM,12,4.0
4,GLVMLVKKAGLT,50.0,>100.0000,μM,12,4.0
LH01,RVKLVNLGFATLREHVP,50.0,>100.0000,μM,17,4.0
DAP2,RWGKWFKKNSHLS,50.0,>100.0000,μM,13,4.0
AmphiArc2 Off2.4,HYIRHLKTWFHKPFKLIGKV,50.0,>100.0000,μM,20,4.0
From_Paper_75,DQEPVE,50.0,>100.0000,μM,6,4.0
From_Paper_76,EDGPHGD,50.0,>100.0000,μM,7,4.0
From_Paper_77,EEVPITD,50.0,>100.0000,μM,7,4.0
From_Paper_78,IAVPHEP,50.0,>100.0000,μM,7,4.0
From_Paper_26,NLHLPLPLLQS,50.0,>100.0000,μM,11,4.0
"EeCentrocin 1 Chain A (1-12)[G1A, D8A, N12K]",AWWRRTVAKVRK,50.0,>100.0000,μM,12,4.0
From_Paper_67,APEELDA,50.0,>100.0000,μM,7,4.0
From_Paper_68,TPRKQ,50.0,>100.0000,μM,5,4.0
5,IIFGVIKALSG,50.0,>100.0000,μM,11,4.0
Alyteserin-2b,ILGAILPLVSGLLSNKL,50.0,>100.0000,μM,17,4.0
From_Paper_86,ESKDQ,50.0,>100.0000,μM,5,4.0
From_Paper_87,EVGMQE,50.0,>100.0000,μM,6,4.0
From_Paper_88,IFGDD,50.0,>100.0000,μM,5,4.0
From_Paper_83,SVLEFS,50.0,>100.0000,μM,6,4.0
From_Paper_79,KNDESVD,50.0,>100.0000,μM,7,4.0
From_Paper_39,VAEDLL,50.0,>100.0000,μM,6,4.0
From_Paper_40,VARLEA,50.0,>100.0000,μM,6,4.0
From_Paper_41,YAGNAP,50.0,>100.0000,μM,6,4.0
From_Paper_42,YDGTPLN,50.0,>100.0000,μM,7,4.0
SVS-3,KVKVKVKVPPTKVKVKVK,50.0,>100.0000,μM,18,4.0
C-10,KWKLFKKIPKFLH,50.0,100.0000,μM,13,4.0
C-7,KWKLFKKIPLAKKF,50.0,100.0000,μM,14,4.0
C-9,KWKLFKKIPLKKF,50.0,100.0000,μM,13,4.0
3A,LTAEHYAAQATS,50.0,>100.0000,μM,12,4.0
13,GLPLFLKKLGSAV,50.0,>100.0000,μM,13,4.0
"Mastoparan-L [A5K,L9R,A10I,I13K,L14I]",INLKKLAARIKKKI,50.0,>100.0000,μM,14,4.0
Tat (48-56) + PPF-BBI [5-15],RKKRRQRRRCWTKSIPPKPC,50.0,100.0000,μM,20,4.0
3,GLKDPLKSVAKHLVK,50.0,>100.0000,μM,15,4.0
17,GLLALLGELAEHLGSKI,50.0,>100.0000,μM,17,4.0
8,GLFKIISGIA,50.0,>100.0000,μM,10,4.0
9,GLGMIAHGV,50.0,>100.0000,μM,9,4.0
14,GLWGVIKALGGHVG,50.0,>100.0000,μM,14,4.0
10,GLWKILKKGA,50.0,>100.0000,μM,10,4.0
HAL-1/4,GMWSKILGHLKR,50.0,>100.0000,μM,12,4.0
Alyteserin-2a [G3K],ILKKLLSTAAGLLSNL,50.0,100.0000,μM,16,4.0
From_Paper_52,EQPLQA,50.0,>100.0000,μM,6,4.0
From_Paper_53,HIDELDE,50.0,>100.0000,μM,7,4.0
From_Paper_54,VPDELN,50.0,>100.0000,μM,6,4.0
BMAP-27(1-18),GRFKRFRKKFKKLFKKLS,50.0,>100.0000,μM,18,4.0
18,GTFAIIQ,50.0,>100.0000,μM,7,4.0
IDP-intwtLN10,RRRRRRRAAKVVILKKATEYVHS,50.0,>100.0000,μM,23,4.0
IDP-intwtL05,RRRRRRRRKRRNDLRSRFLALRDQ,50.0,>100.0000,μM,24,4.0
AmphiArc2 Off2.9,HLIHRLHTYWHKPWHYLGKL,50.0,>100.0000,μM,20,4.0
IDP-wtLN10,AAKVVILKKATEYVES,50.0,>100.0000,μM,16,4.0
From_Paper_89,LGGDL,50.0,>100.0000,μM,5,4.0
From_Paper_101,SEGIQ,50.0,>100.0000,μM,5,4.0
From_Paper_102,SNDPVA,50.0,>100.0000,μM,6,4.0
From_Paper_103,LWGPVT,50.0,>100.0000,μM,6,4.0
From_Paper_104,AWDGQ,50.0,>100.0000,μM,5,4.0
From_Paper_92,FNGVE,50.0,>100.0000,μM,5,4.0
From_Paper_93,FEGPE,50.0,>100.0000,μM,5,4.0
From_Paper_94,LNGPQ,50.0,>100.0000,μM,5,4.0
From_Paper_95,EKGVQ,50.0,>100.0000,μM,5,4.0
From_Paper_96,SKKEV,50.0,>100.0000,μM,5,4.0
From_Paper_100,ANGPE,50.0,>100.0000,μM,5,4.0
From_Paper_90,LQPSLEH,50.0,>100.0000,μM,7,4.0
From_Paper_91,TDPELV,50.0,>100.0000,μM,6,4.0
From_Paper_82,STGTIR,50.0,>100.0000,μM,6,4.0
From_Paper_81,NNDDEES,50.0,>100.0000,μM,7,4.0
From_Paper_80,KTYSA,50.0,>100.0000,μM,5,4.0
IR-13,CIIRRIIRRIIRR,50.0,>100.0000,μM,13,4.0
From_Paper_69,SLEYEFK,50.0,>100.0000,μM,7,4.0
From_Paper_70,PPLENT,50.0,>100.0000,μM,6,4.0
From_Paper_71,AQSSLS,50.0,>100.0000,μM,6,4.0
From_Paper_51,AQDDLP,50.0,>100.0000,μM,6,4.0
From_Paper_73,DFKEELPK,50.0,>100.0000,μM,8,4.0
From_Paper_74,AEDNSL,50.0,>100.0000,μM,6,4.0
From_Paper_59,HGGDDLG,50.0,>100.0000,μM,7,4.0
From_Paper_60,ILEEQ,50.0,>100.0000,μM,5,4.0
From_Paper_61,AGDAW,50.0,>100.0000,μM,5,4.0
From_Paper_62,SAANT,50.0,>100.0000,μM,5,4.0
From_Paper_63,FTEELE,50.0,>100.0000,μM,6,4.0
From_Paper_64,TAEQVA,50.0,>100.0000,μM,6,4.0
From_Paper_65,DAELDK,50.0,>100.0000,μM,6,4.0
From_Paper_66,SLEYLP,50.0,>100.0000,μM,6,4.0
From_Paper_72,PTELESD,50.0,>100.0000,μM,7,4.0
N-5,WKKIPKFLHLAKKF,50.0,100.0000,μM,14,4.0
Lavracin,WDPYFAGVKKLTKAILAVRA,50.0,~100.0000,μM,20,4.0
"Mastoparan-L [I1K,N2I,A5R,L9K,A10I]",KILKRLAAKIKKIL,50.0,>100.0000,μM,14,4.0
LF11-322,PFWRIRIRR,50.0,>100.0000,μM,9,4.0
Desotamide A,NGWLLI,50.0,>100.0000,μM,6,4.0
From_Paper_27,RGPFPI,50.0,>100.0000,μM,6,4.0
From_Paper_28,EFLKEQF,50.0,>100.0000,μM,7,4.0
From_Paper_29,DEDEQPRPIP,50.0,>100.0000,μM,10,4.0
From_Paper_30,LPKILLLQLV,50.0,>100.0000,μM,10,4.0
From_Paper_97,LNDVE,50.0,>100.0000,μM,5,4.0
From_Paper_32,AKDEKEL,50.0,>100.0000,μM,7,4.0
From_Paper_33,DAAEK,50.0,>100.0000,μM,5,4.0
From_Paper_34,DQKVLA,50.0,>100.0000,μM,6,4.0
From_Paper_19,PKLLLLPKP,50.0,>100.0000,μM,9,4.0
From_Paper_20,PFPGPIP,50.0,>100.0000,μM,7,4.0
From_Paper_21,PFPGPIPNS,50.0,>100.0000,μM,9,4.0
From_Paper_22,SGCVNEL,50.0,>100.0000,μM,7,4.0
From_Paper_23,LLLHALL,50.0,>100.0000,μM,7,4.0
From_Paper_24,GRVSNCAA,50.0,>100.0000,μM,8,4.0
From_Paper_31,NWDDMEK,50.0,>100.0000,μM,7,4.0
From_Paper_98,VEKVE,50.0,>100.0000,μM,5,4.0
From_Paper_99,KGGEV,50.0,>100.0000,μM,5,4.0
From_Paper_84,AQKQE,50.0,>100.0000,μM,5,4.0
From_Paper_85,EPKVLV,50.0,>100.0000,μM,6,4.0
From_Paper_16,VKKVFK,50.0,>100.0000,μM,6,4.0
From_Paper_17,HCHTN,50.0,>100.0000,μM,5,4.0
From_Paper_18,PVARMCR,50.0,>100.0000,μM,7,4.0
SFTI-PEDF,CTKSIPPICYHLNQPF,50.0,>100.0000,μM,16,4.0
MIP(Y6A),PRFWEAWLRLME,50.0,>100.0000,μM,12,4.0
TetraF2W-RK,WWWLRKIW,50.0,>100.0000,μM,8,4.0
SFTI-1,CTKSIPPICFPDGR,50.0,>100.0000,μM,14,4.0
CMAP-L-23,KKFFKKMKSFFKKFF,50.0,100.0000,μM,15,4.0
CMAP-L-20,KKFFSKMKSFFKKFF,50.0,100.0000,μM,15,4.0
Peptide-20,CSSRTMHHC,50.0,100.0000,μM,9,4.0
AmphiArc2 Off2.8,RFLKHLHTYYERAWHVIGHL,50.0,>100.0000,μM,20,4.0
NK11,KISKRILTGKK,50.0,>100.0000,μM,11,4.0
PEDF,YHLNQPF,50.0,>100.0000,μM,7,4.0
TetraF2W-KR,WWWLKRIW,50.0,100.0000,μM,8,4.0
MIP(W7A),PRFWEYALRLME,50.0,>100.0000,μM,12,4.0
Unknown,GFWARIGKVFAAVKNL,50.0,101.0000,μM,16,3.9957
LfcinB (17-31),FKARRWQWRMKKLGA,50.0,>102.0000,μM,15,3.9914
Gaegurin 5 (1-11)[V8W],FLGALFKWASK,50.0,102.2000,μM,11,3.9905
LfcinB (20–30),RWQWRMKKLG,50.0,>103.0000,μM,10,3.9872
FKA(7),FKAFKAFKAFKAFKAFKAFKA,103.3,204.6700,μM,21,3.9871
LR(9),LRLRLRLRLRLRLRLRLR,96.7,204.7400,μM,18,3.9858
FLAK57,FAKKLAKKLAKLAL,50.0,103.6900,μM,14,3.9843
R2PLx-22,GIMDTVKNAAKNLAGQLLDKLK,50.0,104.1000,μM,22,3.9825
HDH-LGBP-A2,WLWKAIWKLLK,16.0,6.7300,μM,11,3.9822
DN1,ILGKIVKKLVSDF,50.0,104.2400,μM,13,3.982
KFAK(5),KFAKKFAKKFAKKFAKKFAK,89.0,209.1200,μM,20,3.9719
KFK(6),KFKKFKKFKKFKKFKKFK,77.8,204.9900,μM,18,3.9632
sC18 [E15Del],GLRKRLRKFRNKIKK,35.0,40.0000,μM,15,3.9601
FLAK 50N,FAKLLAKALKLKL,50.0,109.8200,μM,13,3.9593
Cathelicidin Neo1,RRIRFPFPPFPWQWPPAGFPTFHIPRIPRKQ,32.0,32.0000,μM,31,3.9477
"Bac5 (1-17)[P4R,F15W]",RFRRPIRRPPIRPPWYP,32.0,32.0000,μM,17,3.9477
TRPs R8,RRRRWRWWRWWRR,50.0,113.7100,μM,13,3.9442
C-ori,VTFVLIAAK,50.0,114.9000,μM,9,3.9397
DM1,GLFDKWAWWRWRR,50.0,115.5600,μM,13,3.9372
p53 TAD(50-54) Trp-substituted peptide,WEQWW,19.0,10.0000,μM,5,3.9356
"Arenicin-3 [Y5R,V6A], NZ17230",GFCWRACVYRNGVRVCYRRCN,50.0,>116.1881,μM,21,3.9348
FLAK96,FALALKALKKAL,50.0,116.5800,μM,12,3.9334
"Arenicin-3 [Y9K,V15S], NZ17160",GFCWYVCVKRNGVRSCYRRCN,50.0,>116.7311,μM,21,3.9328
LK(12),LKLKLKLKLKLKLKLKLKLKLKLK,60.0,171.5900,μM,24,3.9305
"Arenicin-3 [Y5N,V15I,Y17H], NZ17211",GFCWNVCVYRNGVRICHRRCN,50.0,>117.3714,μM,21,3.9304
"Arenicin-3 [Y5H,V8A,Y9], NZ17224",GFCWHVCARRNGVRVCYRRCN,50.0,>117.3714,μM,21,3.9304
"Arenicin-3 [V8,13A;Y9R], AA139",GFCWYVCARRNGARVCYRRCN,50.0,>117.4642,μM,21,3.9301
"Arenicin-3 [Y5R;V6,15A], NZ17228",GFCWRACVYRNGVRACYRRCN,50.0,>117.4642,μM,21,3.9301
"Arenicin-3 [V6,8A;Y9K;V13L], NZ17126",GFCWYACAKRNGLRVCYRRCN,50.0,>118.1112,μM,21,3.9277
"Arenicin-3 [Y5N,Y9R,Y17H], NZ17143",GFCWNVCVRRNGVRVCHRRCN,50.0,>118.3446,μM,21,3.9269
tPep12,FFWKTKPRKHGGRR,26.17128,~20.0000,μM,14,3.9268
"Arenicin-3 [Y5R,V8A,Y9S,V13L], NZ17125",GFCWRVCASRNGLRVCYRRCN,50.0,118.6531,μM,21,3.9257
GN-12,KWWKIWRWR,50.0,119.7500,μM,9,3.9217
PTP-7c,FLGALFHALSHLL,50.0,>120.0000,μM,13,3.9208
FKA(6),FKAFKAFKAFKAFKAFKA,110.8,238.4900,μM,18,3.9206
FKA(8),FKAFKAFKAFKAFKAFKAFKAFKA,60.4,179.2500,μM,24,3.9161
tPep10,GFKNVALSTARGF,25.80153,~20.0000,μM,13,3.9121
L14,PAWRKARRWAWRMKKLAA,50.0,125.0000,μM,18,3.9031
"Maximin-H5, MH5N",ILGPVLGLVSDTLDDVLGIL,50.0,125.0000,μM,20,3.9031
LK(10),LKLKLKLKLKLKLKLKLKLK,65.0,205.6500,μM,20,3.9004
p53 TAD(50-54),IEQWF,18.0,10.0000,μM,5,3.8939
Z3,KAAKKAWKAWKKAAKAAWKKAA,50.0,128.0000,μM,22,3.8928
Ranatuerin-2,GLFLDTLKGAAKDVAGKLEGLKCKITGCKLP,50.0,128.0000,μM,31,3.8928
B18KL,GFQKVKAQALTCLHTVMA,50.0,>128.5000,μM,18,3.8911
M2,GIGKFLHSAKKWGKAFVGEIMNS,50.0,128.9000,μM,23,3.8897
DN4,ILGKIWKGIVSDF,50.0,129.8800,μM,13,3.8865
B18K,GFQKVKAQAATCNHTVMA,50.0,>131.0000,μM,18,3.8827
coloy(Trp-Val-Val-Ala-Ile-Phe),WVVAIF,50.0,131.6800,μM,6,3.8805
PL-D 22,HQFRFRFRVRRK,50.0,131.7000,μM,12,3.8804
(RW)3,RWRWRW,50.0,132.0000,μM,6,3.8794
PL-D 38,RRWKIVVIRWRR,50.0,132.3000,μM,12,3.8784
Cyclic PuroA,FPVTWRWWKWWKG,50.0,>134.1800,μM,13,3.8723
LR(7),LRLRLRLRLRLRLR,86.5,262.6900,μM,14,3.8704
DM2,GLFDIWAWWRWRR,50.0,>135.2700,μM,13,3.8688
GN-8,IWKRWWWKR,50.0,137.7400,μM,9,3.8609
PL-D 39,RLWRIVVIRVKR,50.0,138.4000,μM,12,3.8589
GN-11,IKWKRWWWR,50.0,>138.4300,μM,9,3.8588
tPep1,FLPIPRPILLGLL,24.44698,~20.0000,μM,13,3.8578
V5,CAKAKAKAGSGAKAKAKAC,50.0,140.0000,μM,19,3.8539
KFAK(4),KFAKKFAKKFAKKFAK,76.0,260.9100,μM,16,3.8534
FLAK 50E,FAKLLKLAAKKLL,50.0,140.7100,μM,13,3.8517
GN-14,RLWKRWWIR,50.0,>142.8900,μM,9,3.845
PBP,KKLIKVWAKGFKKAKKLFKGIG,21.0,15.0000,μM,22,3.8422
L2,PAWFKARRWAWRMKKLAA,50.0,144.0000,μM,18,3.8416
GN-9,RIWKIWWKR,50.0,>145.8100,μM,9,3.8362
PL-D 13,RWWRWRKWW,50.0,147.5000,μM,9,3.8312
FLAK 50H,FAKLLAKLAKAKL,50.0,148.4300,μM,13,3.8285
Esculentin (1-21),GIFSKLAGKKIKNLLISGLKG,50.0,150.0000,μM,21,3.8239
Pleurocidin VA,GWGSFFKKAAHAGKHAGKAALTHYL,50.0,>150.6600,μM,25,3.822
PTPRJ-pep19.3,CHANLTHAC,51.0,160.0000,μM,9,3.8171
coloy(Trp-Thr-Tyr-Ile-Phe),WTYIF,50.0,152.3900,μM,5,3.817
PL-D 7,RRWWKWWWR,50.0,152.6000,μM,9,3.8164
Dermaseptin S4 (1-26)a,ALWMTLLKKVLKAAAKAALNAVLVGA,42.19,96.0500,μM,26,3.8156
Citropin-c,GLFAVIHHVASVIGGL,50.0,156.0000,μM,16,3.8069
PL-D 40,RLRRIVVIRVFR,50.0,158.8000,μM,12,3.7991
Cationic Amphiphilic,GIIKKIIIKKI,50.0,160.0000,μM,11,3.7959
"Bac5 (1-17)[P4W, P9R, F15W]",RFRWPIRRRPIRPPWYR,28.0,32.0000,μM,17,3.7948
ND5,GLFDRVKKRKSLF,50.0,>160.6100,μM,13,3.7942
DN5,ILGKRWKGRVSDF,50.0,>163.9100,μM,13,3.7854
DN2,ILGKIWKKLVSDF,50.0,>165.4900,μM,13,3.7812
PL-D 14,KRWWWWRFR,50.0,166.7000,μM,9,3.7781
PL-D 20,RIKRWWWWR,50.0,167.2000,μM,9,3.7768
From_Paper_109,QESDAKKYGVGGYFQGLLSQ,24.749,25.0000,μM,20,3.773
FLAK50 Z9,FAFAKIIAKIAKKII,50.0,170.1300,μM,15,3.7692
PL-D 21,RWRWWWRVY,50.0,171.5000,μM,9,3.7657
RN3(5-17P22-36)[W8I],RPFTRAQIFAIQHISPRTIAMRAINNYRWR,50.0,171.5500,μM,30,3.7656
A4,GLFDIVKKLVSDF,50.0,>172.8900,μM,13,3.7622
Z2,KAAKKWAKAWKKAAKAWKKAA,50.0,173.0000,μM,21,3.762
PL-D 48,YKFRWRIYI,50.0,173.3000,μM,9,3.7612
DN3,ILGKIWKGLVSDF,50.0,>173.4700,μM,13,3.7608
PL-D 8,KIWWWWRKR,50.0,173.9000,μM,9,3.7597
PL-D 47,NWRKLYRRK,50.0,174.9000,μM,9,3.7572
"Bac5 (1-17)[F2W; P4W; P9,17R; Y16W]",RWRWPIRRRPIRPPFWR,27.0,32.0000,μM,17,3.7555
TRPs WW,WWRWWKWW,50.0,176.1000,μM,8,3.7542
PL-D 42,RRYHWRIYI,50.0,176.9000,μM,9,3.7523
PL-D 29,RWWRKIWKW,50.0,177.3000,μM,9,3.7513
FLAK96B,FALALKLAKKAL,50.0,178.7600,μM,12,3.7477
PL-D 16,RRWWRWVVW,50.0,179.1000,μM,9,3.7469
Hepcidin-25,DTHFPICIFCCGCCHRSKCGMCCKT,26.0,30.0000,μM,25,3.7439
PL-D 30,LRFILWWKR,50.0,181.0000,μM,9,3.7423
PL-D 31,RWWIRIRWH,50.0,181.8000,μM,9,3.7404
FLAK 54,FAKKLAKKLAKAL,50.0,181.8400,μM,13,3.7403
PL-D 11,RIRRWKFRW,50.0,182.5000,μM,9,3.7387
BPC136,KKLLKFLKKQ,29.0,40.0000,μM,10,3.7368
From_Paper_113,PVCRKEKKDGKRCVARYVEHFAGKDRRMQA,23.83632,25.0000,μM,30,3.7362
TRPs W8,WRWWKWWK,50.0,183.6100,μM,8,3.7361
PL-D 43,RKWKIKWYW,50.0,183.8000,μM,9,3.7357
KFAK(3),KFAKKFAKKFAK,77.0,346.7900,μM,12,3.7327
From_Paper_112,YRKCDTAGGLSKLCVAEKDIKIIWKYGGR,23.71267,25.0000,μM,29,3.7312
Z1,KAAKKWAKAAKKAAKAWKKAA,50.0,186.0000,μM,21,3.7305
Z1,KAAKKWAKAAKKWAKAWKKAA,50.0,186.0000,μM,21,3.7305
PL-D 35,WKIVFWWRR,50.0,186.0000,μM,9,3.7305
PL-D 23,LKRRWKWWI,50.0,186.7000,μM,9,3.7289
Brevinin-1Ha,FALGAVTCLIRTKCKVLPKLF,50.0,186.9000,μM,21,3.7284
PL-D 49,KRKKRFKWW,50.0,188.0000,μM,9,3.7258
PL-D 33,LRRWIRIRW,50.0,189.1000,μM,9,3.7233
PL-D 17,WFKMRWWGR,50.0,189.3000,μM,9,3.7228
PL-D 24,RRRIKIRWY,50.0,190.2000,μM,9,3.7208
PL-D 34,RKFRWWVIR,50.0,190.2000,μM,9,3.7208
PL-D 27,FFIYVWRRR,50.0,190.8000,μM,9,3.7194
PL-D 44,YRLRVKWKW,50.0,191.9000,μM,9,3.7169
PL-D 25,RLWWKIWLK,50.0,192.8000,μM,9,3.7149
PL-D 26,KRRWRIWLV,50.0,195.1000,μM,9,3.7097
PL-D 36,RQRRVVIWW,50.0,197.2000,μM,9,3.7051
PL-D 37,RRWRVIVKW,50.0,197.2000,μM,9,3.7051
FLAK120,KWKKLAKKW,50.0,197.4400,μM,9,3.7046
Modifed Thermo2,IHKLVKLWLNLGKKF,50.0,>200.0000,μM,15,3.699
[Lys18] Ascaphin-8,GFKDLLKGAAKALVKTVKF,50.0,200.0000,μM,19,3.699
Modifed Opero3,ILKPKLWKLTVVARKIIK,50.0,200.0000,μM,18,3.699
Modifed Opero1,IPLLRKGKKIIWW,50.0,>200.0000,μM,13,3.699
"EeCentrocin 1 Chain A (1-12)[W3A, D8A, N12K]",GWARRTVAKVRK,50.0,>200.0000,μM,12,3.699
EeCentrocin 1 Chain A (1-16),GWWRRTVDKVRNAGRK,50.0,>200.0000,μM,16,3.699
"EeCentrocin 1 Chain A (1-12)[D8A, R11A, N12K]",GWWRRTVAKVAK,50.0,>200.0000,μM,12,3.699
Chensinin-1,SAVGRHGRRFGLRKHRKH,50.0,>200.0000,μM,18,3.699
Modifed Coco1,FTILKKLKSFIK,50.0,>200.0000,μM,12,3.699
"EeCentrocin 1 Chain A (1-12)[W2A, D8A, N12K]",GAWRRTVAKVRK,50.0,>200.0000,μM,12,3.699
[Lys10] Ascaphin-8,GFKDLLKGAKKALVKTVLF,50.0,>200.0000,μM,19,3.699
[Lys14] Ascaphin-8,GFKDLLKGAAKALKKTVLF,50.0,200.0000,μM,19,3.699
BP16,KKLFKKILKKL,50.0,>200.0000,μM,11,3.699
"EeCentrocin 1 Chain A (1-12)[R5A, D8A, N12K]",GWWRATVAKVRK,50.0,>200.0000,μM,12,3.699
"EeCentrocin 1 Chain A (1-12)[R4A, D8A, N12K]",GWWARTVAKVRK,50.0,>200.0000,μM,12,3.699
Modifed Thermo1,ITKWLLNAIKKGFKL,50.0,>200.0000,μM,15,3.699
Modifed Coco2,KLVKKLLKKYITF,50.0,200.0000,μM,13,3.699
Modifed Thermo3,LFSIIWKLNRKLIKA,50.0,>200.0000,μM,15,3.699
"EeCentrocin 1 Chain A (1-12)[D8A, K9A, N12K]",GWWRRTVAAVRK,50.0,>200.0000,μM,12,3.699
"EeCentrocin 1 Chain A (1-12)[V7A, D8A, N12K]",GWWRRTAAKVRK,50.0,>200.0000,μM,12,3.699
Modifed Pyro1,IVIKSLGKFLKNVGGFAG,50.0,>200.0000,μM,18,3.699
EeCentrocin 1 Chain A (1-16)[D8A],GWWRRTVAKVRNAGRK,50.0,>200.0000,μM,16,3.699
"EeCentrocin 1 Chain A (1-12)[D8A, N12K]",GWWRRTVAKVRK,50.0,>200.0000,μM,12,3.699
BPC154,KLLKLFKKKQ,28.0,40.0000,μM,10,3.6979
TRPs W7,WRWWKWW,50.0,202.6900,μM,7,3.6932
LfcinB (20–25),RRWQWR,50.0,>203.0000,μM,6,3.6925
PL-D 45,WKWRVRVTI,50.0,206.0000,μM,9,3.6861
PL-D 46,RTKKWIVWI,50.0,208.3000,μM,9,3.6813
"LTV-HEXIM1 (147-164, LTV-BR",LTVSPWYGCGQLGKKKHRRRPSKKKRHW,30.0,50.0000,μM,28,3.6783
Granulysin (42-61),RDVCRNFMRRYQSRVIQGLV,20.0,20.0000,μM,20,3.676
"Bac5 (1-17)[F2,15W]",RWRPPIRRPPIRPPWYP,25.0,32.0000,μM,17,3.6759
Z10,AAKKWAKAKWAKAKKWAKAA,50.0,>211.0000,μM,20,3.6757
TRPs R7,RWWKWWK,50.0,>212.7000,μM,7,3.6722
tPep17,FLGKKVLKAVGKQAAKKQME,19.65104,~20.0000,μM,20,3.6616
PL-D 28,IRMRIRVLL,50.0,219.0000,μM,9,3.6596
BPC84,KLKKLFKKLQ,27.0,40.0000,μM,10,3.6586
sesquin,KTCENLADTY,85.0,432.0625,μM,10,3.6526
FLAK91B,FAKLAKKALAKLL,50.0,222.6400,μM,13,3.6524
FLAK50T8,VAKLLAKLAKKVL,50.0,225.8300,μM,13,3.6462
[Lys1] XT-7,KLLGPLLKIAAKVGSNLL,50.0,230.0000,μM,18,3.6383
FLAK50J,FAKLLAKLAKKAA,50.0,233.1100,μM,13,3.6324
FLAK50 Q10,FKLAFKLAKKAFL,50.0,236.0800,μM,13,3.6269
tPep7,SIVLRGKAPFR,18.75682,~20.0000,μM,11,3.6244
TRPs R6,RWWKWW,50.0,>238.7300,μM,6,3.6221
tPep13,PRLRRLTGLSPLRAP,18.53871,~20.0000,μM,15,3.6154
FLAK50 Q9,FAKLFAKLAKKFAL,50.0,250.6200,μM,14,3.601
FLAK96D,FALLKALKKAL,50.0,250.9100,μM,11,3.6005
KSL-7,FKVKFKVKVK,50.0,251.8800,μM,10,3.5988
FLAK 58,FAKKLAKKLAKAAL,50.0,253.1800,μM,14,3.5966
"Bac5 (1-17)[F2R; P4,9R; I6W; P17W]",RRRRPWRRRPIRPPFYW,23.0,32.0000,μM,17,3.595
FLAK97,FALKALKK,50.0,261.3900,μM,8,3.5827
BPC82,KKLKLFKKLQ,25.0,40.0000,μM,10,3.579
FLAK62 AM,FALAKKALKKAKKAL,50.0,267.0200,μM,15,3.5735
LK(11),LKLKLKLKLKLKLKLKLKLKLK,43.8,187.0800,μM,22,3.5728
KFAK(2),KFAKKFAK,83.0,516.9500,μM,8,3.5719
KSL-1,KKVVFKVKFK,50.0,271.8700,μM,10,3.5656
Tat (47-57),YGRKKRRQRRR,35.0,~100.0000,μM,11,3.5621
PYL-ME,KIAKVALAKLGIGAVLKVLTTGL,50.0,278.7700,μM,23,3.5548
"Bac5 (1-17)[F2W; P4,9,17R; I6W]",RWRRPWRRRPIRPPFYR,22.0,32.0000,μM,17,3.5542
"Bac5 (1-17)[P4,17W; P9R]",RFRWPIRRRPIRPPFYW,22.0,32.0000,μM,17,3.5542
FLAK50 T5,FAKLLAKLAKKSL,50.0,279.5600,μM,13,3.5535
"Penetratin, Antp, Sequence 3 from Patent US 20030077289",RQIKIWFQNRRMKWKK,50.0,281.0000,μM,16,3.5513
FLAK50 Z5,FAKLWAKLAKKL,50.0,282.3300,μM,12,3.5492
LK(9),LKLKLKLKLKLKLKLKLK,46.0,228.3100,μM,18,3.546
novispirin G-10,KNLRRIIRKGIHIIKKYG,33.2,90.6300,μM,18,3.5399
FLAK50T7,FAKLLAKLAKKGL,50.0,292.6900,μM,13,3.5336
FLAK50 Z8,FAKIIAKIAKIAKKIL,50.0,296.7300,μM,16,3.5276
FLAK50 Q2,FAKLLFKALKKAL,50.0,298.4700,μM,13,3.5251
Amurin-2a,FLPLLLAGLPSFLCLVFKKC,50.0,302.1000,μM,20,3.5198
Dermaseptin S4 (7-28),LKKVLKAAAKAALNAVLVGANA,35.72,119.9300,μM,22,3.5086
Amurin-2a [S11K],FLPLLLAGLPKFLCLVFKKC,50.0,310.6000,μM,20,3.5078
BPC90,KLKLKFKKLQ,23.0,40.0000,μM,10,3.4981
BPC102,KKKLKFLLKQ,23.0,40.0000,μM,10,3.4981
FLAK50 Z3,FAKAIAKIAFGKGIGKVGKKLL,50.0,327.6000,μM,22,3.4847
Bim SM-1,IWIAQELRRIGDEFNA,25.0,50.0000,μM,16,3.4821
"Bac5 (1-17)[P4W; P9,17R; Y16W]",RFRWPIRRRPIRPPFWR,20.0,32.0000,μM,17,3.4719
PBP-A,KKAAKAWAKGAKKAKKLAKGAG,12.0,15.0000,μM,22,3.465
BPC74,KKLKKFLKLQ,22.0,40.0000,μM,10,3.4573
BPC186,KKKLKFKKLQ,22.0,40.0000,μM,10,3.4573
BPC128,KKKLLFLKKQ,22.0,40.0000,μM,10,3.4573
ALA-A2,KLWCKSSQVPQSR,40.3,200.0000,μM,13,3.4391
Bac5 (1-17)[Y16W],RFRPPIRRPPIRPPFWP,19.0,32.0000,μM,17,3.4304
"Bac5 (1-17)[F2W; P4,9R; P17W]",RWRRPIRRRPIRPPFYW,19.0,32.0000,μM,17,3.4304
LK(8),LKLKLKLKLKLKLKLK,43.5,256.5900,μM,16,3.4271
"Temporin-1Sa [S3K,F13L], SEQ ID NO:5 for Patent EP 2853538 A1",FLKGIVGMLGKLL,50.0,376.0000,μM,13,3.4248
FLAK 75,FAKKLKKLAKKL,50.0,381.4000,μM,12,3.4186
FLAK50 Q8,FAKLLAKLAKKFAL,50.0,396.9300,μM,14,3.4013
GW-A4,GAKALTKAATAFTKFYKTIW,50.0,404.0000,μM,20,3.3936
LFB 14-31 (L1),PEWFKCRRWQWRMKKLGA,50.0,>404.0000,μM,18,3.3936
NK19a,KISKKIMRTFLRRILTGKK,21.1,43.1420,μM,19,3.3875
FLAG26-D1,FAKKLAKLAKKL,50.0,419.5000,μM,12,3.3773
CMAP-L-253,KKKKFFMFVFFKKKK,30.0,~100.0000,μM,15,3.3773
CMAP-L-202,KKFFSKSMKSFFFFKK,30.0,>100.0000,μM,16,3.3773
BPC192,LKLLKFKKLQ,20.0,40.0000,μM,10,3.375
BPC160,KLLLKFKKKQ,20.0,40.0000,μM,10,3.375
FLAK77,FAKKALKALKKL,50.0,423.1800,μM,12,3.3735
VISHNU3,MPKEKVFLKIEKMGRNIRN,50.0,428.8400,μM,19,3.3677
WR8,WRRRRRRRR,50.0,442.0000,μM,9,3.3546
"Bac5 (1-17)[F2,15W; P4R]",RWRRPIRRPPIRPPWYP,17.0,32.0000,μM,17,3.347
FLAK-120F,WALAL,50.0,453.9900,μM,5,3.343
Flak 96L,LKKLAKLALAF,50.0,456.5800,μM,11,3.3405
FLAK96F,FALALKALKK,50.0,462.6200,μM,10,3.3348
BPC148,KKLLLFKKKQ,19.0,40.0000,μM,10,3.3335
BPC118,KKLLKFKLKQ,19.0,40.0000,μM,10,3.3335
FLAK-120D,FALALKLKKL,50.0,480.5600,μM,10,3.3183
Diketopiperazine (GI),GI,28.45,100.0000,μM,2,3.3175
"Bac5 (1-17)[F2W, P4R]",RWRRPIRRPPIRPPFYP,16.0,32.0000,μM,17,3.305
"Bac5 (1-17)[P4W; P9,17R]",RFRWPIRRRPIRPPFYR,16.0,32.0000,μM,17,3.305
GW-H1-scr,KYLNFAKWLKGANLAKYANA,50.0,>500.0000,μM,20,3.301
CMAP-L-233,KKKKFFMSFFFKKKF,28.0,~100.0000,μM,15,3.2999
FLAK50 Q4,FAKLLAKAFKKAL,50.0,503.8500,μM,13,3.2977
BPC132,KLKKLFLKKQ,18.0,40.0000,μM,10,3.2919
BPC196,LLKLKFKKLQ,18.0,40.0000,μM,10,3.2919
KFAK(1),KFAK,112.0,1015.0000,μM,4,3.2916
FLAK-120G,VALALKALKKL,50.0,513.9100,μM,11,3.2891
Flak 96J,FALALKLAKKL,50.0,526.5000,μM,11,3.2786
Ixosin [H3A],GLAKVMREVLGYERNSYKKFFLR,8.0,16.0000,μM,23,3.2664
CMAP-L-243,KKKKFFMLVKKKKFF,27.0,~100.0000,μM,15,3.2607
FLAK50 T1,FAKLLAKLAK,50.0,557.8700,μM,10,3.2535
BPC114,KLKKLFKLKQ,17.0,40.0000,μM,10,3.2501
BPC106,KLKKKFLLKQ,17.0,40.0000,μM,10,3.2501
PTPRJ-pep19.2,CAHNLTHAC,32.0,160.0000,μM,9,3.2487
FLAK26-D2,FAKKLAKLAKKLAKAL,50.0,573.9700,μM,16,3.2411
FLAK94,FALALKA,50.0,586.7000,μM,7,3.2316
FLAK50K,FAKLLAKLAKAKA,50.0,597.3500,μM,13,3.2238
FLAK90,FAKLA,50.0,601.4500,μM,5,3.2208
"Bac5 (1-17)[F2W, P4W, P17R]",RWRWPIRRPPIRPPFYR,14.0,32.0000,μM,17,3.2207
BPC162,LKLLKFKKKQ,16.0,40.0000,μM,10,3.2081
BPC164,LLKLKFKKKQ,16.0,40.0000,μM,10,3.2081
FLAK50 Z2,FAFGKGIGKVGKKLL,50.0,639.8200,μM,15,3.1939
Ixosin (12-23),YERNSYKKFFLR,28.0,128.0000,μM,12,3.1927
FLAK80,FAKLLAKKLL,50.0,646.5800,μM,10,3.1894
FLAK50 Z7,FAFGKGIGKIGKKGL,50.0,657.5200,μM,15,3.1821
"HEXIM1 (147-164)[K4,5,6,13,14,15R], BR-RRR12",QLGRRRHRRRPSRRRRHW,25.0,100.0000,μM,18,3.181
"Bac5 (1-17)[P4,9,17R]",RFRRPIRRRPIRPPFYR,13.0,32.0000,μM,17,3.1784
FLAK50 Q5,FAKLFAKAFKKAL,50.0,674.3800,μM,13,3.1711
Esculentin (1-18),GIFSKLAGKKLKNLLISG,20.0,64.0000,μM,18,3.1709
FLAK50 T4,FAKLLAKLAKKEL,50.0,678.9500,μM,13,3.1682
BPC130,KKLKLFLKKQ,15.0,40.0000,μM,10,3.166
Hepcidin-20,ICIFCCGCCHRSKCGMCCKT,12.0,30.0000,μM,20,3.164
FLAK50T9,YAKLLAKLAKKAL,50.0,698.9000,μM,13,3.1556
KFAK(6),KFAKKFAKKFAKKFAKKFAKKFAK,30.5,174.4800,μM,24,3.1546
Ixosin (1-12),GLHKVMREVLGY,27.0,128.0000,μM,12,3.1534
FLAK92B,KAKLAKKALAKLL,50.0,716.4200,μM,13,3.1448
FLAK50L,FAKLLAKLAKAKG,50.0,735.9900,μM,13,3.1331
FLAK50 Z1,FGKGIGKVGKKLL,50.0,743.6700,μM,13,3.1286
FLAK50 Z10,FAKIIAKIAKKI,50.0,744.1900,μM,12,3.1283
BPC110,KKKLLFKLKQ,14.0,40.0000,μM,10,3.1238
BPC188,LLLKKFKKLQ,14.0,40.0000,μM,10,3.1238
BPC76,KLKKKFLKLQ,14.0,40.0000,μM,10,3.1238
Diketopiperazine (GV),GV,23.46,100.0000,μM,2,3.1189
FLAK50 Z6,FAKGVGKVGKKAL,50.0,767.6900,μM,13,3.1148
FLAK93,KWKLF,50.0,769.8700,μM,5,3.1136
Cr-ACP1,AWKLFDDGV,50.0,800.0000,μM,9,3.0969
"Bac5 (1-17)[F2W; P4,17R]",RWRRPIRRPPIRPPFYR,11.0,32.0000,μM,17,3.0934
FLAK50T6,FAKLLAKLAKK,50.0,812.6200,μM,11,3.0901
BPC78,LKKKKFLKLQ,13.0,40.0000,μM,10,3.0815
BPC92,LKKLKFKKLQ,13.0,40.0000,μM,10,3.0815
FLAK96G,FALLKL,50.0,838.1800,μM,6,3.0767
VS-9,VKLRSLLCS,50.0,840.0000,μM,9,3.0757
FAKK(6),FAKKFAKKFAKKFAKKFAKKFAKK,28.3,174.4800,μM,24,3.0699
Flak 96H,FALALKALKKA,50.0,852.1600,μM,11,3.0695
FLAK121,FALAKALKKAL,50.0,852.1600,μM,11,3.0695
FLAK96C,FALKALKKAL,50.0,852.6800,μM,10,3.0692
Modelin-8D,KFKKLAKKF,50.0,879.1500,μM,9,3.0559
FLAK91,FAKLF,50.0,880.3200,μM,5,3.0554
"Bac5 (1-17)[F2,15W; P4W]",RWRWPIRRPPIRPPWYP,10.0,32.0000,μM,17,3.0508
"Bac5 (1-17)[P4,9,17R; Y16W]",RFRRPIRRRPIRPPFWR,10.0,32.0000,μM,17,3.0508
FLAK81,FAKKLAKALL,50.0,907.1000,μM,10,3.0423
FLAK-120C,FALALKAKKL,50.0,907.1000,μM,10,3.0423
BPC120,LKKLKFKLKQ,12.0,40.0000,μM,10,3.039
BPC146,LLKKKFLKKQ,12.0,40.0000,μM,10,3.039
CTLEW,CTLEW,50.0,922.0300,μM,5,3.0353
CMAP-L-241,KKFFKLVKKKMKKFF,21.0,~100.0000,μM,15,3.0183
CMAP-L-252,KFKKFFKFMVKKKKF,21.0,~100.0000,μM,15,3.0183
CMAP-L-232,KKFFKKMSFFFFKKK,21.0,~100.0000,μM,15,3.0183
FLAK83M,FAKLAKKLL,50.0,969.6200,μM,9,3.0134
"Bac5 (1-17)[F2,15W; P4,9R]",RWRRPIRRRPIRPPWYP,9.0,32.0000,μM,17,3.0081
Ixosin,GLHKVMREVLGYERNSYKKFFLR,9.0,~32.0000,μM,23,3.0081
"Bac5 (1-17)[P4,17R]",RFRRPIRRPPIRPPFYR,9.0,32.0000,μM,17,3.0081
"Bac5 (1-17)[F2,15W; P4,9,17R]",RWRRPIRRRPIRPPWYR,9.0,32.0000,μM,17,3.0081
Pen13,KIWFQNRRMKWKK,50.0,>1000.0000,μM,13,3.0
PenLeu,RQIKIWFQNRRLKWKK,50.0,>1000.0000,μM,16,3.0
PenLys,KQIKIWFQNKKMKWKK,50.0,>1000.0000,μM,16,3.0
BPC104,KKLKKFLLKQ,11.0,40.0000,μM,10,2.9965
BPC200,LLLLKFKKLQ,11.0,40.0000,μM,10,2.9965
BPC150,KLKLLFKKKQ,11.0,40.0000,μM,10,2.9965
MAP-04-04,KRLRRVWRRWR,20.0,>100.0000,μM,11,2.977
"Bac5 (1-17)[F2W, P4W]",RWRWPIRRPPIRPPFYP,8.0,32.0000,μM,17,2.9654
"Bac5 (1-17)[P4W, F15W]",RFRWPIRRPPIRPPWYP,7.0,32.0000,μM,17,2.9226
ROS modulator 1 (58-78),KTMMQSGGTFGTFMAIGMGIR,20.0,115.1800,μM,21,2.9157
BPC112,KKLKLFKLKQ,9.0,40.0000,μM,10,2.9112
BPC108,LKKKKFLLKQ,9.0,40.0000,μM,10,2.9112
BPC80,KKKLLFKKLQ,9.0,40.0000,μM,10,2.9112
LK(7),LKLKLKLKLKLKLK,29.6,292.8600,μM,14,2.8953
SOR-C13,KEFLHPSKVDLPR,18.0,~100.0000,μM,13,2.8939
FTLE,FTLE,38.0,600.0000,μM,4,2.8874
RFAR(6),RFARRFARRFARRFARRFARRFAR,22.1,156.1600,μM,24,2.8699
BPC126,LLKKKFKLKQ,8.0,40.0000,μM,10,2.8685
BPC86,LKKKLFKKLQ,8.0,40.0000,μM,10,2.8685
Diketopiperazine (GL),GL,17.25,100.0000,μM,2,2.8626
"Bac5 (1-17)[F2R;P4,9,17R;F15W]",RRRRPIRRRPIRPPWYR,5.0,32.0000,μM,17,2.8368
"Bac5 (1-17)[P4,9,17R; F15W]",RFRRPIRRRPIRPPWYR,5.0,32.0000,μM,17,2.8368
Bac5 (1-17)[P17R],RFRPPIRRPPIRPPFYR,5.0,32.0000,μM,17,2.8368
Bac5 (1-17)[P17W],RFRPPIRRPPIRPPFYW,5.0,32.0000,μM,17,2.8368
"Bac5 (1-17)[F2R; P4,9R; F15W]",RRRRPIRRRPIRPPWYP,5.0,32.0000,μM,17,2.8368
Ixosin (4-23),KVMREVLGYERNSYKKFFLR,19.0,128.0000,μM,20,2.8284
BPC144,LKLKKFLKKQ,7.0,40.0000,μM,10,2.8257
BPC122,KLLKKFKLKQ,7.0,40.0000,μM,10,2.8257
"OGF, 7",YGGFM,16.1,100.0000,μM,5,2.8144
FKA(9),FKAFKAFKAFKAFKAFKAFKAFKAFKA,20.9,159.4500,μM,27,2.8116
"Bac5 (1-17)[F2W; P4,9,17R; Y16W]",RWRRPIRRRPIRPPFWR,4.0,32.0000,μM,17,2.7938
NK19b-KR,RILRGVSRRIMRRILTGRR,6.6,42.2672,μM,19,2.7846
BPC100,KKKKLFLLKQ,6.0,40.0000,μM,10,2.7828
FLAK92,KAKLF,50.0,1650.7900,μM,5,2.7823
PTPRJ-pep19.7,CHHNLTAAC,20.0,160.0000,μM,9,2.7729
CMAP-L-201,KKKKFFSMSFFKKFF,15.0,~100.0000,μM,15,2.7681
BPC166,LLLKKFKKKQ,5.0,40.0000,μM,10,2.7398
BPC116,LKKKLFKLKQ,5.0,40.0000,μM,10,2.7398
PTPRJ pep-19.5,CHHNATHAC,19.0,160.0000,μM,9,2.7315
PTPRJ-pep19.6,CHHNLAHAC,19.0,160.0000,μM,9,2.7315
PTPRJ-pep19,CHHNLTHAC,19.0,160.0000,μM,9,2.7315
"Bac5 (1-17)[P4W, P9R]",RFRWPIRRRPIRPPFYP,2.0,32.0000,μM,17,2.7077
BPC124,LKLKKFKLKQ,4.0,40.0000,μM,10,2.6969
BPC70,KKKKLFLKLQ,4.0,40.0000,μM,10,2.6969
BPC66,KLKKKFKLLQ,4.0,40.0000,μM,10,2.6969
"EP5, Antimicrobial peptide OEP3121",ACSAG,48.12,1840.8000,μM,5,2.6923
"Bac5 (1-17)[F2W; P4,9R]",RWRRPIRRRPIRPPFYP,1.0,32.0000,μM,17,2.6646
"Bac5 (1-17)[F2W; P4,9,17R]",RWRRPIRRRPIRPPFYR,1.0,32.0000,μM,17,2.6646
Ixosin (7-18),REVLGYERNSYK,15.0,128.0000,μM,12,2.6609
BPC134,LKKKLFLKKQ,3.0,40.0000,μM,10,2.6539
NK13,KISKKIMRTFLRR,6.4,59.6263,μM,13,2.6266
FLAK-120B,FALA,50.0,2378.1200,μM,4,2.6238
FKA(10),FKAFKAFKAFKAFKAFKAFKAFKAFKAFKA,15.0,143.5800,μM,30,2.611
BPC72,KKKLKFLKLQ,2.0,40.0000,μM,10,2.6108
BPC158,LLKKLFKKKQ,2.0,40.0000,μM,10,2.6108
Ixosin (1-18),GLHKVMREVLGYERNSYK,13.0,128.0000,μM,18,2.5763
P17,YQEPVLGPVRGPFPIIV,41.49,1597.7000,μM,17,2.5735
BPC156,LKLKLFKKKQ,1.0,40.0000,μM,10,2.5677
Tat,RKKRRQRRR,10.0,~100.0000,μM,9,2.556
BF2d,TRSSRAGLQWPVGRVHRLLRKGGC,10.0,~100.0000,μM,24,2.556
AMP 21,LRKVRRLLRRL,10.0,100.0000,μM,11,2.556
p53 TAD(50-54) Ala-substituted peptide,AEQAA,21.0,300.0000,μM,5,2.5412
RFAR(7),RFARRFARRFARRFARRFARRFARRFAR,12.4,133.9600,μM,28,2.5311
Cathelicidin-RC1,KKCKFFCKVKKKIKSIGFQIPIVSIPFK,4.3,60.9000,μM,28,2.5272
P19,SLPQNIPPLTQTPVVVPPF,38.55,1467.4000,μM,19,2.5172
KFAK(7),KFAKKFAKKFAKKFAKKFAKKFAKKFAK,13.0,149.6900,μM,28,2.5083
LTV-X13,LTVSPWYGCGMPFSTGKRIMLGE,0.0,50.0000,μM,23,2.4277
"Antimicrobial peptide 1, Cn-AMP1",SVAGRAQGM,5.8,100.0000,μM,9,2.3763
"HEXIM1 (147-164), BR",QLGKKKHRRRPSKKKRHW,5.0,100.0000,μM,18,2.3419
MSL,MSL,23.0,600.0000,μM,3,2.322
"Chionodracine [F1W; H4,15,17K; I9K; S11,21K]",WFGKLYRGKTKVVKKVKGLLKG,0.0,64.0000,μM,22,2.3205
BCP-A,WPP,50.0,4994.2300,μM,3,2.3015
V2,CVKVSVKVGSGVKVSVKVC,50.0,5660.0000,μM,19,2.2472
HCAP18(109-135),FRKSKEKIGKEFKRIVQRIKDFLRNLV,88.0,11984.2900,μM,27,2.2128
AKKF(6),AKKFAKKFAKKFAKKFAKKFAKKF,7.3,174.4800,μM,24,2.1988
Ixosin (4-18),KVMREVLGYERNSYK,3.0,128.0000,μM,15,2.1487
AMP 23,LRKFRRLLRRL,0.0,100.0000,μM,11,2.1266
KFFK(7),KFFKKFFKKFFKKFFKKFFKKFFKKFFK,0.0,129.1000,μM,28,2.0157
MEDEI,MEDEI,15.0,600.0000,μM,5,1.9899
"Ovalbumin (277-287)[V5R, P8R, K11I]",RKIKRYLRRMI,10.0,391.4000,μM,11,1.9633
LKKL(7),LKKLLKKLLKKLLKKLLKKLLKKLLKKL,0.0,147.2000,μM,28,1.9587
Ovalbumin (277-287),RKIKVYLPRMK,10.0,399.4900,μM,11,1.9545
"Reverse Tachyplesin [C3,7,12,16Del]",RRRYIGRYVRFWK,50.0,12100.0000,μM,13,1.9172
LKKL(6),LKKLLKKLLKKLLKKLLKKLLKKL,0.0,171.5900,μM,24,1.8921
LKKL(5),LKKLLKKLLKKLLKKLLKKL,0.0,205.6500,μM,20,1.8135
m3,KGIRDWLRGFNKLRKWFLRLIKGL,50.0,19902.7400,μM,24,1.7011
m1,RLYRLYFRLYRLWRRLTL,50.0,23455.0900,μM,18,1.6298
KL15,KRKLYKWFAHLIKGL,50.0,26297.1000,μM,15,1.5801
m2,RLWRLAWRLYRLWRLTL,50.0,29512.5800,μM,17,1.53
m5,LRLLDRWLRLFNRLLRWLRLLRGL,50.0,31606.7600,μM,24,1.5002
m4,LRRLDRWLRLFNRLRRWFLRLLRGL,50.0,32399.5400,μM,25,1.4895
"Tachyplesin [C3,7,12,16Del]",KWFRVYRGIYRRR,50.0,37180.0000,μM,13,1.4297
